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INTRODUCTION 
 
“kWg;gJ  cly; Neha;  kUe;njdyhFk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
kWg;gJ  csNeha;  kUe;njdyhFk;; ; ; ;; ; ; ;; ; ; ; 
kWg;gJ  ,dpNeha;  thuhjpUf;f; ; ;; ; ;; ; ;  
kWg;gJ  rhit  kUe;njdyhNk”; ;; ;; ;  
- jpUke;jpuk;; ;; ;; ; 
The word siddha comes from the word siddhi which means a perfection or 
heavenly bliss. 
The masters of this ancient medical science are called as ‘Siddha’s. They are 
greatest spiritual scientists who are highly cultured intellectuals with spiritual 
insight and personal discipline. 
These siddhars  evaluvated several approaches (Noi Nadal) and methods of 
preparation of medicine to provide an optional health and symphony of life to the 
patient . 
Siddhars formulated the drugs through their spiritual intuition, not through their 
experiments with animals or humans 
According to Siddhar’s, medicine is defined as the combination of substances or 
methods that cures physical and mental ailment and prevent diseases to help 
mankind to live immortal life. 
Siddha system clearly underlines the classic concept of “Pancha Bootha System” 
1. The Macro cosum (Universe) 
2. The Micro cosum (Body) 
“mz;lj;jpy; cs;sNj gpz;lk;”; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
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They hold that the universe is a macro cosum made up of 5 pridominal 
elements or “Pancha Boothas” viz Nilam (earth), Neer (Water), Neruppu 
(Fire), Vali (wind) and Veli (Space) and the human being is a micro cosum 
made up of these 5 elements. 
When there is a change in equilibrium of this 5 elements in macro cosum it 
influence the equilibrium of 5 elements in micro cosum. This imbalance leads 
to the course of a diseases. 
In the present universe, the environment is highly disturbed (imbalanced). The 
air is polluted, water is contaminated, and food is adulterated. Also the human 
mind is adulterated at a will. These changes cause several diseases in humans. 
One such the disease the human are suffering is Swetha Kuttam in modern 
medicine Swatha Kuttam is related to Leucoderma or Vitiligo. 
Even before several centuries siddhar yugi as classified skin disease under 
a generic name called “Kuttam” as 18 types. Swetha Kuttam is one of them. 
• Vitiligo affects 1% of the population  
• Common in all races, predominant in dark skin  
• The sex incidence is equal  
• Onset, usually between 10 and 30 years of age 
• The course is unpredictable 
• About 30% of patients give a family history. 
The author has selected to study the compound “Puvarasam Pattai Kudineer 
Chooranam” as internal medicine in the treatment of swetha kuttam.  
The author has also selected the compound “Nuna Thailam” as external 
application in the treatment of swetha kuttam. 
It is to be noted that the author has selected “Herbs” (Mooligai) as the first 
choice of medicine, when compared to metal (Thathu) minerals of animal 
origin (Seevan). 
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It is because the author has a strong belief in the saying, 
“Nth;g;ghU jiog;ghU kpQ;rpdf;fhy; 
gw;g nre;Jhuk; ghh;” 
The intention of this study of the author is to educate, help, treat and uplift the 
lives of patients suffering from swetha kuttam. Let the God hear the voices and 
cries of the suffering. 
. 
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AIM AND OBJECTIVES 
Aim: 
About 20 to 30% problems in human being pertain to dermatology, lot of interest 
has been developed in this field. Hence this study was carried out with an 
intention to study the “Swethakuttam” in various aspects with modern comparison 
and to formulate an apt treatment that would be given to the patient  through 
Siddha Medicine. 
 
Objectives: 
This Scientific work on Swethakuttam was carried out to assess: 
1. The incidence of this disease with age, gender, occupation, social, status 
diet, seasonal variation.  
2. To  collect the review of the disease dealing with definition, etiology, 
classification, signs and symptoms, prognosis, treatment and diet for  
Swethakuttam. 
3. To correlate the signs and symptoms of Swethakuttam with that of modern 
science. 
4. To expose siddha diagnostic principles. 
5. To find out the quality safety and efficacy of the trail drug by doing 
- Chemical Analysis 
- Acute and sub acute toxicity Studies 
- Pharmacological Studies 
 
6.  To find out the side effect or adverse reactions if any,  
7.  To Evaluate the Clinical efficacy of trail drugs. 
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REVIEW OF LITERATURE 
SIDDHA ASPECTS 
Swetha Kuttam 
(Swetha – White) 
 
Swetha Kuttam is a Chronic Skin disease Characterized by various sizes of hepo 
pigmentary patches in the skin. 
According to Yugi Munivar classification Swetha Kuttam is one among the 18 
types of Kuttam. 
Okiz<!hq{qgt<!29z<!< < << < << < < b,gqLeq!hGh<hqe<hc!SOukGm<ml<!NeK< < < << < < << < < < !
!
“kch<hie!kut<<< fqxl<!Ohiz<!ouTk<Ks<< < < << < < << < < <!
sr<uir<gLl<!ouTk<kix<xie<< < < < < << < < < < << < < < < <!xqVl<Hl<< << << <!
lch<hig!lbqi<ouTk<ki!zsik<bliGl<< < < < << < < < << < < < <!
uiqUkMkt<!tr<jg< << << < g<< <<Gkr<Gb<bf<< < << < << < <!
ofch<hig!ofVh<Hhm<mK!Ohix<H{<{ib<< < < < < << < < < < << < < < < <!
fqxlqVf<ki!zs<<< ik<kqbole<Ox!Bjvg<gizGl<< < < << < < << < < <!
ouch<hig!Oleqobz<zil< << << < <!ouTk<K!uQr<gqz<< < Q < << < Q < << < Q < <!
ou{<SOuk!Gm<mole<Ox!uqtl<hziOl< < < << < < << < < < ” 
! ! ! ! ! ! .b,gq!sqf<kil{q!<<< –!911)hg<gl<!2:9*!< << << < !
! !
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!
• kutfqxl<!Ohiz<!ouTh<H< < << < << < < !
• dkM!dt<tr<jg!ofVh<Hhm<mK!Ohiz<!H{<< < < < < << < < < < << < < < < <!
• Oleq!wz<zil<!ouTk<K!uQr<gz<< < < Q < << < < Q < << < < Q < <!
• lbqi<!ouTk<kz<< < << < << < <!
  
Siddha literatures states that if the lesions are present in lips, palms soles anal and 
genital region are incurable.  
Pigmentary disease are common and particularly distressing to those with darker 
skin. 
Ofib<!uVl<!upq< << << <  (Aetiology)!
Aetiological Analysis of Siddha literature  
Thirumoolar Karukkidai Vaithiya Nool 
 
uqbikqBt<!&uiX!uqtr<gqb!Gm<mr<Ogt<< < < < << < < < << < < < <!
Sbikqg<!gqvf<kq!gpe<!Olgk<kiZl<< < < < << < < < << < < < <!
Hbikq!l{<[tqh<!hzu{<c!eiouzm<M< < < << < < << < < < !
fQbikqh<!hPfizib<!fqe<xkqg<!Gm<mOlQ < < < < <Q < < < < <Q < < < < < ”!
. kqV&zi<!<<< .!
 
• Six types of kuttam, are caused by kiranthi noi Meha Noi 
• Eight types are caused by Inserts in the soil (l{<[tqh<< << << <HP?!u{<M*<<< !
• Four types are caused by worms  
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According to yugi vaidhya Chindhamani 800 
“uqtl<hOu!lqgf<k!d< << << < ]<{f<ke<!eiZl<< < < << < < << < < <!
lqGf<k!sQktk<kiZ!lpx<sq!biZl<< Q < < << Q < < << Q < < <!
utl<hOu!lf<kk<kiz<!uif<kq!biZl<< < < < < << < < < < << < < < < <!
lgk<kie!oh{<O{iM!lVuziZl<< < << < << < <!
gqtl<hOu!gqOzsr<ge<!lqGkziZl<< < < << < < << < < <!
ogcbie!Uxg<gr<gt!jm< << << < ukziZl<<<<!
ktl<hOu!lbqVgx<gt<!kuqM!l{<gt<< < < < << < < < << < < < <!
sikk<kqx<!hVgziz<!lqGg<Gr<!G< < < < << < < < << < < < < ]<ml<< << << <” << <<!
hg<gl<!w{<!2::< < << < << < < !
The above said literature clearly indicates that the predisposing factors of the 
diseases are  
• Excessive heat and cold, allergy                                                                    
• Vomiting due to indigestion  
• Hyper sexual indulgence.  
• Mental disturbance 
• Excessive sleep in day time  
• Frequent intake of food mixed with polluted stone husk and hair 
!
Gm<mf<kie<!hkqoem<M!uvOu!oke<eqx<< < < < < << < < < < << < < < < <!
GVfqf<jk!squfqf<jk!ljxObi< << << < i<!fqf<jk< << << < !
kqm<mf<kie<!Okjujbk<!K~< < < << < < << < < < ]j{g<G!Ovikl<< << << <!
osh<hzix<!xqVmzix<!hvkivk<jk< < < << < < << < < < !
nm<mf<ki!eijsbiz!jmg<g!zk<jk< < < << < < << < < < !
nhgiqk<k!zgkqhv!Oksq!ke<je< << << < !
um<mf<kie<!jukizii<!gx<hpqk<kz<< < < < < < << < < < < < << < < < < < <!
uf<kqMOl!hkqoem<M!Gm<mf<kie<< < < < << < < < << < < < <!
.hg<gl<!w{<!2::< < << < << < < !
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• Use of indescent and disrespectful words against God and highly Religious 
and noble people.   
• Intention to spoil others  
• Raping  
• Greed  
• Cursing the elders and soon have also been given as predisposing causes by 
yugi test 
 
These habits are supposed to be the factors which lower the immunity of the body 
(Eyarkkai vanmai) and make it vulnerable to the disease. 
According to Agasthiyar Kanma Kandam   
Osi<f<k!Gm<mOliM!GjxOfib<gt<!uf<k< < < < < << < < < < << < < < < < !
Oskq!Ogt<!lzvik!uVl<H!ogib<kz<!< < < << < < << < < < !
kiiqf<!sQuosf<K!ujkgt<!osb<kz<!< Q < < < << Q < < < << Q < < < < !
kib<kf<jk!leK!ofif<K!Ovif<!kiOe< < < << < < << < < < !
kioee<x!okb<uV!kjebpqk<kz<!< < < << < < << < < < !
sii<uie!ohiqObii<gt<!kjlh<!hpqk<kz<!< < < < < << < < < < << < < < < < !
gioee<x!ff<kuel<!h,R<oscgt<!oum<mz<!< < < < < < << < < < < < << < < < < < < !
gVllmi!siQ!vk<kqx<!giSOhiOzQ < <Q < <Q < < !
Doee<x!Uml<ohz<zil<!ohim<M!ohim<mi< < < < < << < < < < << < < < < < !
Bme<!ouTk<K!GjxOfiBkqvR<!sqf<Kl<!< < < < << < < < << < < < < !
uioee<x!gVlr<gt<!kQi<h<hkx<G!< < < Q < < << < < Q < < << < < Q < < < !
ujgobie<E!osiz<Oue<!Ogt<< < < << < < << < < <!
! ! ! ! ! ! ! ! .hg<gl<!w{<< < << < << < <.325!
9 
 
lzvik! nVl<H! ogit<kz<?! sQu! osf<Kgjt! ujkgt<! osb<kz<! ohx<Oxii<!
lejk! ofiGl<hc! osb<kz<! ohiqObii<gt<! kl<jl! hpqk<kz<! ff<kuel<!
h,R<oscgt<! oum<Mkz<! Ngqb! -g<giv{r<gtiz<! Gm<mOfib<! uVl<! we<X!
ngk<kqbi<!ge<l!gi{<mk<kqz<!%xh<hm<Mt<tK/!
sqk<k!lVk<Ku!sqxh<H!–!F~zqe<hc;.!
2/ Okizqz<!K{q!Lkzqbux<xiz<!uqmilz<!Wx<hMl<!dvib<U!
3/ K~l<hx<x!SvhqfQi<gtqe<!uqgx<hl<!
4/ ofgp<!ohiVt<gt<!Okizqz<!ncg<gc!dvib<kz<!!
5/ sk<kx<x!d{U!
6/ -f<Ofib<!yVujg!gilqbk<kiz<!hqxg<Gl<!!
7/ uqz!-l<lqgt<!Gjxf<K!Ohikz<!)n*!-z<zilz<!-Vk<kz<!!
8/ OlgOfib<?!ogiXg<G!Ofib<g<G!Kj{bigUl<!!
9/ okiPOfibqZl<!ou{<hjm!gi[l<!
:/ OlgOfibqZl<?! okiPOfibqZl<! uVl<! ou{<hjm! okix<Xl<! lx<xju!!
okix<xikju!
 
As analysed in Siddha  system predisposing causes for this disease waries from 
hereditary, factor, stress and strain, mal nutrition and venereal exposure, no other 
specific causes have been mentioned for Swethakuttam. 
• nPgqb! lQe<?! f{<M?! fk<jk?! sqh<hq?! -jugjt! lqGkqBl<!d{<mhqe<!!!!!!!!!!!
Obigfqjzbqz<!-Vk<kz<!!
• Ougi! d{Ugjt! ogit<tz<?! ubqX! fqjxb! d{<m! hqe<!
Obigfqjzbqz<!-Vk<kz</!!
• ke<uqje?!hpuqje?!kib<!
• kf<jk!upqbigUl<!hqxg<Gl< 
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Classification: 
According to Yugi Vaidhya Chinthamani 
!
Lk<kiGl<!Gm<mf<kie<!hkqoem<Mg<Gl<< < < < < < < << < < < < < < << < < < < < < < 
Leqbie!b,gqfie<!osizzg<!Ogtib<< < << < << < <!
Hk<kiGl<!H{<miQg!G< < < Q< < < Q< < < Q ]<mk<OkiM< << << < !
ohiVgqe<x!uqx<Ohimgg<!Gm<mliGl<< < < < << < < < << < < < <!
hk<kiGl<!hili!G< << << < ]<m!Wgsi<l!G< << << < ]<ml<< << << <!
hiquie!gi<eG<<< ]<ml<!si<lG< < << < << < < ]<mr<< << << <!
gqk<kiGr<!gqV< << << < ]<{!Gm<ml<!nUKl<hv!Gm<ml<< < < < < << < < < < << < < < < <!
Ogcbie!l{<mz!G<<< ]<mliG!ole<Oe< << << < !
Gm<mli!hiqs!G<<< ]<m!OliM<<< !
lVuzir<!gqCh!G<<< ]<mf<!si<lkz!G< < << < << < < ]<mf<< << << <!
kqm<mlix<!kk<KV!G< < << < << < < ]<m!OliM<<< !
kg<gie!sqk<Kli!G< << << < ]<mR<!skiV!G< << << < ]<mf<< << << <!
Km<mliR<!SOuk!G< << << < ]<mke<!Oeiomig<gs<< < < << < < << < < <!
Sbl<hie!hkqoem<Mg<!Gm<mlis<Os< < < < << < < < << < < < < !
.hg<gl<!w{<;!2:2< < << < << < < !
1. Pundareeka kuttam 
2. Virpodaka kuttam 
3. Baama kuttam 
4. Gaja saruma kuttam 
5. Karna kuttam 
6. Sarma kuttam 
7. Krishna kuttam 
8. Avudhumbara kuttam 
9. Mandala kuttam 
10. Abarisa kuttam 
11. Visarchika kuttam 
12. Vibaathika kuttam 
13. Kideeba kuttam 
14. Sarmathala kuttam 
15. Thethru kuttam 
16. Sithuma kuttam 
17. Sathaaru kuttam 
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18. Swetha kuttam 
Swetha Kuttam is also called as Venpadai. 
1. According to Siddhar Aruvai Maruthuvam  
Venpadai has been classified into 3 types on the basis of Mukkutram they 
are, 
1. Vaatha Venpadai 
2. Pitha Venpadai 
3. Kaba Venpadai 
 
Clinical Features: 
1. The Skin appears glittering and tough 
2. There is an excessive perspiration or no perspiration  
3. Discolouration 
4. Heat and itching of the skin 
5. Numbness in some parts of the body 
 
2. According to Sirappu Maruthuvam 
1. Vaatha Venpadai 
2. Pitha Venpadai 
3. Kaba Venpadai 
4. Mega Venpadai 
 
(i) Vaatha Venpadai 
 
It is characterized by the depigmented patches, which are dry, rough and reddish 
with somewhat pale-black colour. 
(ii) Pitha Venpadai 
 
It is Chracterized by the depigmented patches red in colour like lotus flower, 
spreading with burning sensation and loss of hairs on that area. 
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(iii) Kaba Venpadai  
 
It is characterized by the depigmented patches white in colour like leucus flower, 
spreads with rashes and itching. 
(iv) Mega vepadai  
 
It is due to the veneral diseases and it occurs after 4 or 6 months after the onset of 
disease, syphilis within four or six months of the attack. This venpadai develops 
initially along the nape and the adjoining spaces. Also gradually it affects the 
shoulder joints, back of trunk. Clinical features of this type are clearly defined by 
the author of Siddha Maruthuvam Sirappu” as follows: 
   
Depigmented patches are small in number, pale in colour, with turmeric colour or 
dark colour margin marked with hyperpigmented signs. These lesions are 
circumscribed with 2mm to 3mm diameter or above. This correct picture of 
hypopigmented and hyper-pigmented skin seems to be more or less a multi eyed 
filter (sieve-like). 
Females are more prone to this Mega Venpadai. Therefore anti syphilitic therapy 
is mandatory in the early period of the treatment. 
According to Athma Rakshamirtha Vaidhtya Sarasankiraham 
Swethakuttuam is classified into 4 types 
1. Venkuttam 
2. Senkuttam 
3. Karunkuttam 
4. Peru Viyathi 
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Clinical Features of Kutta Rogam 
1. According to Agasthiyar Ayulvedham 1200 
 
“djvk<kii<!hkqOepr<G< < << < << < < m<mLx<x!siQvLmz<!ouTg<g< < Q < << < Q < << < Q < < !
zqVf<Kl<!hkqoem<mir<Gm<m!lqklib<!oki{<jmk<!kiegm<Ml<!< < < < < < < < < << < < < < < < < < << < < < < < < < < < !
ohVk<k!siQvl<!out<jt!!hx<xqh<!ohVg<g!KbvL{<miGl<!< Q < < < < < < << Q < < < < < < << Q < < < < < < < !
uVk<kr<gi[l<!hkqoem<mil<!ujgbir<!Gm<mujg!osie<Oeil<< < < < < < < < << < < < < < < < << < < < < < < < <”!
.!hg<gl<!w{<;346< < << < << < < !
2. According to Thanvanthiri Vaithyam 
 
“lQg<ogtk<!OkiXolZOliiQ < <Q < <Q < < <!Lgl<!ouTg<Gligqz<!< < < << < < << < < < !
Ofig<gqbz<!liqg<GR<!osie<e!ou{<Gm<mliOl< < < < < < << < < < < < << < < < < < < ” 
.hg<gl<!w{<;42:< < << < << < < !
 
3. According to Vaidhya Saarasangiraham 
 
* Sole, hands, lips, scalp, fingers and wrist joint – all organs are found with 
white coloured patches which are circumscribed along with thickened border 
and gradually spread which is known as “Swetha Kuttam”.  
* Blood, muscle and adipose tissue are affected by disease.  
* Dislocation of hairs, absence of normal skin texture comparing the adjoining 
normal skin area and appearance of burns is not curable. 
4. According to Anubhava Vaidhiya Deva Ragasiyam 
 
-f<Ofijb!G<<< ]<mole!%xqEl<!-K!G< << << < ]<m!ujggtqeqe<X!OuXhm<mK!< < << < << < <
we<hjkbl<! G< << << < ]<mk<jkh<! Ohiz<! nu<utU! ogiMjlbie! uqbikq!< < < < << < < < << < < < <
nz<zoue<Xl<!d{v! Ou{<Ml</! -f<Ofibqz<! kqm<M! kqm<mig! ou{<jl!< < < < < < < < < << < < < < < < < < << < < < < < < < < <
fqxlie! hjmgt<! d{<migq! hqxG! Okgl<! L< < << < << < < PuKl<! hvuq! dmjz!<<<
uqgivh<hMk<Kkz<!G{r<gjt!djmbK< < < << < < << < < < ”/!
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.hg<gl<!w{<;319< < << < << < < !
Character of Swetha Kuttam 
Skin colour will change to reddish black or reddish white or white colour with 
spreading nature. The imbalance of the three thathu produces certain lesions in 
skin known as kuttam.  
Absence of perspiration and thickening of skin may produce the colour changes in 
skin. 
!
kQVl<?!kQvikjuQ < QQ < QQ < Q  
In Thanvanthiri Vaithiyam 
sik<kqbl<!< << << < .!22!
!
“h,{<mf<!FvuqOeiM!skiiqgl<!H{<miQ!gf<k!< < < < Q << < < < Q << < < < Q < !
ki{<M!uqx<Ohiml<!hiliUme<!jlkzl<!ou{<Gm<ml<!< < < < < < < << < < < < < < << < < < < < < < !
%{<cM!gig<<< xf<kq!sqXjl!bsz!Gm<ml<!< < << < << < < !
Ou{<cb!uqbikqObiMl<!hkqoeie<Xl<!uqiqk<Kg<!giOe< < < < < << < < < < << < < < < < ”/!
.hg<gl<!w{<;436< < << < << < < !
!
nsik<kqbl<!< << << < .!8!
!
“osiz<ZGm<ml<!WPujgOhi<!osiz<zqg<!ghiz!si<lQgl<< < < < < < < Q << < < < < < < Q << < < < < < < Q <!
ouz<Z!LKl<hi!Olgqchl<!uqsi<s<sql{<mzg<!gqvLl<< < < < < < < << < < < < < < << < < < < < < <!
lz<zz<!kVlQsq!bGju!biGl<!ohbOvi!OvpiGl<< < Q < << < Q < << < Q < <!
uz<zgqbikqg<!G{l< << << < kje!uGk<kh<!hiiqZXjvh<OhOe< < << < << < < ”/!
.hg<gl<!w{<;!432< < << < << < < !
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Curable -11 
1. Thethuru Kuttam 
2. Sadhaaru Kuttam 
3. Pundareega Kuttam 
4. Virpodaga Kuttam 
5. Sama thala Kuttam 
6. Baama Kuttam 
7. Kaha Nandhi Kuttam 
8. Venkuttam 
9. Sithuma Kuttam 
10.  Alasakuttam 
11. Vibaathiga Kuttam 
 
Incurable -7  
1. Kabaala Kuttam 
2. Sarumamega Kuttam 
3. Avudhumbara Kuttam 
4. Kideeba Kuttam 
5. Visarchika kuttam 
6. Aguvai Kuttam 
7. Mandala Kuttam 
 
In Yugi Vaidhya Chinthamani -800 
Gm<mf<kie<!hkqoem<cz<!sik<kqbf<kie<!< < < < < < < << < < < < < < << < < < < < < < !
%xg<Ogt<!uqx<ohimg!hili!Gm<ml<< < < < << < < < << < < < <!
kqm<mf<kie<!ogssi<l!Gm<moliM< < < < << < < < << < < < < !
gqVm<ce!Gm<mlUKl<hv!< < << < << < < Gm<mf<kiEl<< < << < << < <!
kqm<mlif<!OkkqkqVg<!!Gm<moliM< < < << < < << < < < !
osb<sqk<Kli!Gm<mr<!gqch!Gm<ml<< < < < < << < < < < << < < < < <!
km<mf<kie<!lqGf<k!skiV!Gm<ml<< < < < < << < < < < << < < < < <!
slgqVm<{!Gm<ml<!sik<kqbli!ole<Oe< < < < << < < < << < < < < ”/!
.hg<gl<!w{<;311< < << < << < <  
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Curable-10 
1. Virpodaka kuttam 
2. Baama Kuttam 
3. Gaja Saruma Kuttam 
4. Krishna Kuttam 
5. Avuthumbara Kuttam 
6. Thethuru Kuttam 
7.  Sithuma Kuttam 
8.  Kideepa Kuttam 
9. Sathaaru Kuttam 
10.  Sarmathla Kuttam 
 
Incurable-8 
1. Pundareeka Kuttam  
2. Karna Kuttam  
3. Sikura Kuttam 
4. mandala Kuttam 
5. Abarisa Kuttam 
6. Visarchika Kuttam 
7.  Swetha Kuttam 
8. Vivadhika Kuttam 
 
According to Siddha literature if the lesions are present in palms, soles, anal 
region, genitalia area incurable,. The patches look like burns is also incurable. 
Mukkutra Verupadugal (Pathogenesis): 
“uiklziK!Oleq!ogmiK”!
.!Okjvbi<<<<!
.!Ofib<!fimz<!Ofib<!Lkz<!fimz<!kqvm<M< < < < < << < < < < << < < < < < !
.!hg<gl<!w{<;799< < << < << < <  
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Inappropriate diet 
 
 
Vali Vitiated 
 
 
/+ Azhal + iyam 
 
 
Udal Kattugal affected 
 
 
/ (Especially Saaram, Senneer) 
 
Disease 
 
THINAIGAL – LANDS (GEOGRAPHICAL AREA) 
 
Geography affects a person in a same manner as the seasons. Nilam is classified 
into 5 types, depending upon the surrounding, Vegetation, landscape and 
ecological state. 
 
Study of the five lands is very necessary, because certain diseases are vulnerable 
in certain lands. 
 
S.No. Thinaigal / lands Geographical 
area 
Common diseases  
 
1. Kurinji – Hilly trea Mountains & its 
Surroundings 
Iya noi, Liver 
Diseases  
2. Mullai – Sylvian Tract Forest its 
Surroundings 
Azal, Vali, Liver  
Diseases 
3. Marutham – Fertile area Fields & its 
Surroundings 
Ideal place for 
healthy Living 
4. Neithal – Coastal Area Sea & its 
Surroundings 
  
Vali diseases, 
Liver 
Diseases 
5. Paalai – Arid area Desert & its 
Surroundings 
Vali Azhal Iyam  
Diseases 
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 Each region has got its own characteristics features which influence the 
inhabitant’s mental, physical, economic, occupational and cultural activities. In 
each region, on the basis of its peculiar physical and climatic features, some 
ailments are endemic. The preventive and curative measures for these ailments are 
stated in the medical literature. 
 
PARUVAKALAM /( SESONAL EFFECTS): 
 
Because of the climate changes, which are the results of solar, lunar and planetary 
effects, natural changes take place in the earth and its atmosphere as well as 
human body. A certain change in the aggravation, displacement of aggravation or 
normal sign of Mukkutram during different seasons in normal and the biological 
processes in the body become adapted to these changes. 
 
SIDDHARS described six seasons in a year and each constituting two months 
some of the diseases are more prevalent during the particular Paruvakalam 
(season) and study of it will be of much use of diagnosis. 
 
Here is a table of the Principle seasonal effects: 
  
S.No. Kaalam Synonym Kutram Suvai 
1. Kaar Kaalam  
(Aug 16 –Oct 15) 
Early Rainy Vali Azhal ↑ Inippu, 
Pulippu, Uppu 
2. Koothir Kaalam 
(Oct. 16 – Dec.15) 
Late Rainy 
(Autumn) 
Vali (-) 
Azhal ↑ 
Inippu, Kaippu, 
Thuvarppu 
3. Munpani Kaalam  
(Dec.16-Feb.15) 
Early dew  
(Winter I Part) 
 
Azhal (-) 
Inippu, 
Pulippu, Uppu 
4. Pinpani Kaalam 
(Feb.16 – April 16) 
Late dew 
(Winter II Part) 
 
Iyam 
Inippu, 
Pulippu, 
Thuvarppu 
5. Elavenil Kaalam 
(April 16 –June 15) 
 
Early Summer 
 
Iyam ↑↑ 
Kaippu, 
Karppu,  
Thuvarppu 
6. Muthuvenil 
Kaalam 
(June 16- Aug. 15) 
 
Later Summer 
Vali ↑ 
Iyam (-) 
 
Inippu 
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↑ Accumulation (Thannilai Valarchi) 
↑↑ Aggravation (Vetrunilai Valarchi) 
(-)  Alleviation (Thannilai Adaithal) 
 
In every season there will be changes in the land, water, plants, animals and 
human beings, which will modify the physiology and making (rendering) them 
susceptible to certain specific disease which are common in these seasons. The 
siddhars have been anticipating these changes and advised certain measures in the 
form of diet, purgative exercises, etc, to avoid the onset of such ailment. 
 
UYIR THATHUKKAL / MUKKURTRAM: 
 
These are all the main three pillars which functions the body with an equilibrium 
state. Any disturbance in that state leads to diseased condition in our body. 
 
The three pillars are 
 
1. Vali  
2. Azhal 
3. Iyam 
 
(i) VALI or VAYU: 
 
Vali is not mere wind, but also that which causes motion, energy and sensation of 
every cell in the body. Vayu relates to nerve force. It is responsible for all 
movements in the mind and the body. In human body it controls the Gnanedriyam 
(sensory actions) & Kanmendriyam (motor activities). 
 
Vali generally lives in: 
 
Abaanan, Edakalai, kamakodi, Undhiyin Keezh Moolam, Hip region, Bones, 
Muscles, Nerves, Joints, Skin, Hair follicles, Stools. 
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Varieties of Vali: 
 
According to their location and functions they are classified into 10 types. 
 
1. Uyirkkal (Pranan) 
2. Kezhnokkum kaal (Abaanan) 
3. Parravukaal (Viyanan) 
4. Melnokkum Kaal (Udhanan) 
5. Nadukkaal (Samanan) 
6. Naagan 
7. Koorman 
8. Kirugaran 
9. Devadhathan 
10. Thananjeyan 
 
 
1. Uyirkkaal (Pranan) (Heart Centre) 
 
It regulates the respiratory, cardiac and digestive system. By joining with pingalai, 
it forms azhal naadi. It is responsible for bio confusion in the body. 
 
In Swetha Kuttam, Uyirkkaal may be affected. 
 
2. Kezhnokkum Kaal (Abaanan) Mooladharam Centre) 
 
It regulates the defaecation, micturation, menstruation, parturition and ejaculation. 
It corresponds to the pelvic plexus and the lower part of the gut. 
 
3. Paravukaal (Viyanan) (fore head centre) 
 
It spreads all over the body and all nerve endings. It regulates constriction and 
relaxation of the voluntary and involuntary musles. The neurological problems 
were due to this Vayu. It spreads the nutrients to all over the body form the 
digested food. 
 
4. Mel Nokkumkaal (Udhanan) 
 
It is responsible for speech, vomit, hiccough and sneeze. 
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5. Nadukkaal (Samanan): 
 
It is responsible for digestion and it spreads the nutrients all over the body. 
Joining with suzhumunai forms the Kaba naadi. It neutralizes the other four 
Vayus. 
 
6. Naagan: 
 
It is responsible for the intelligence and derangement of this Vayu causes 
Impaired memory. It helps to opening and closure of eyelids. 
 
7. Koorman: 
 
This is responsible for the vision, Yawning and Lacrimal secretions. 
 
8. Kirugaran: 
 
It is responsible for salivation, nasal secretion, hunger, sneeze, cough and 
concentration. 
 
9. Devadhathan: 
 
It is responsible for laziness and anger. 
 
 
10. Thananjeyan: 
 
It produces swelling all over the body and leaves from cranium only after the 3rd 
day after death. It is responsible for the decay of the body after death. 
 
II. AZHAL:  
 
This is nothing but the characteristics of fire such as burning, boiling and heating 
etc. It corresponds to the functions of i.e. thermogenesis production of heat 
necessary to maintain integrity of the human circulatory system. Azhal is 
classified into 5 types. It mainly governs enzymes & hormones.  
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Seats of azhal: 
 
Between heart & the navel, Sweat, lymph, blood, stomach, urinary bladder, saliva 
eye and skin. 
 
S.No. Name Location Function 
 
1. Akkuanal (Analagam) Stomach Small 
intestine 
Dissolvent & 
Digestive 
2. Vanna eri (Ranjagam) Liver, Spleen, 
Stomach 
Colouring, Pleasin, 
Gratifying 
3. Attralangi (Sathagam) Heart Effective efficient 
4. Nokku Azhal (Alosagam) Eyes Seeing, consideration 
5. Ollolithee (Prasagam) Skin Complexion of the 
skin 
 
In Swetha Kuttam, Vannaeri (Ranjagam), Ollolithee (Prasagam) were 
affected. 
 
III. IYAM 
 
It imparts moisture. Iyam is located in samanan semen, head, tongue, flat, bone 
marrow, blood, nose, chest, nerves, brain, large intestine, eyes, stomach & 
pancreas. 
 
S.No. Name Location Function 
 
1. Alli Iyam (Avalambagam) Lung Supports all the other 
2. Neerpi Iyam (Kilethagam) Stomach Moistens and nourishes 
the food 
3. Survaikanna Iyam 
(Pothagam) 
Tongue Take care of perception 
4. Niraivu Iyam (Tharpagam) Head Refrigerant effect to 
eyes 
5. Ondri Iyam (Santhigam) Joints Stability, Lubrication & 
movements of joints 
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Since Swetha kuttam patients are not having defined description of pathology, the 
pattern of disturbance in Vali, Azhal, iyam keeps on varying. The Manifestation 
of these uyir thathus keep on changing according to the predominant symptom. 
But alteration in azhal thathu is seen mostly. 
 
UDAL KATTUGAL : (SEVEN PHYSICAL CONSTITUENTS) 
 
1. Saaram – Chyle (Plasma) 
 
It is responsible for the growth & development. It keeps the individual in good 
spirit and nourishes the blood. 
In Swetha Kuttam, Saaram may be affected.  
 
2. Senner – Blood 
 
Blood imparts colour to the body and nourishes the muscle for the ability. 
In Swetha Kuttam, Senneer may be affected. 
 
3. Oon – Muscle: 
 
Gives shape to the body. 
 
4. Kozhuppu – Fat:  
 
It helps in lubricating the different organs and maintains oily matter of the body. 
 
 
5. Enbu – Bone: 
 
It supports the system and responsible for the posture movement of the body. 
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6. Mulai - Marrow 
 
It fills the bone cavity, nourishes semen and imparts strength, endurance and shiny 
appearance.  
 
7. Sukkilam or Suronitham (Sperm & Ovum): 
 
It is responsible for the reproduction. 
 
RELATIONS BETWEEN SEVEN UDAL THATHUS & MUKKUTRAM 
 
S.No. Udal Kattugal Governing 
Kutrams 
Bootham 
 
1. Saaram (Plasma) Iyam (Kabam) Neer 
2. Senneer (Blood) Azhal 
(Pitham) 
Thee + Neer 
3. Oon (Muscle) Iyam (Kabam) Mann + Neer 
4. Kozhuppu (Fat) Iyam (Kabam) Mann + Neer 
5. Enbu (Bone) Vali (Vatham) Mann + Vali 
6. Mulai (Marrow) Iyam (Kabam) Neer + Vali 
7. Sukkilam/Suronitham 
(Reproductive tissues) 
Iyam (Kabam) Neer 
 
PINIYARI MURAIMAI – (DIAGNOSIS) 
 
The methodology of diagnosing in siddha science is very unique and solely based 
on the clonical acumen of the physician. It is based on the three main principles. 
 
1. Poriyal Aridhal 
2. Pulanal Aridhal 
3. Vinaathal 
 
“Pori” is the five organs of perception namely Nose, Tongue, Eyes, Ears and skin. 
“Pulan” is the five objects of senses smell, taste, vision, auditory and sensation 
respecti vely corresponding to “Pori”. Poriyalarithal and Pulanal Therthal go hand 
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in hand with the concept to examining the patients “Pori” and “Pulan” with that of 
the “patient’s Pori and Physicians Pulan”. 
 
Vinaadhal (Interrogation) 
 
The physician should interrogate about the patients name, age, occupation, diet, 
habits, and nativity, socio economic status, if prone to any allergens, complaints, 
History of previous and present illness, family and personal history, duration of 
illness.  
 
Enn Vagai Thervugal (Eight diagnostic methods in Siddha): 
 
It is the unique and special method in Siddha. 
 
“fich<!hiqsl<!fifqxl<!olipquqpq< < << < << < < !
lzl<!Lk<kqvlqju!lVk<KuviBkl<< < < << < < << < < <”  
“olb<g<Gxqfqxl<!okieq!uqpqfi!-Vlzl<!jgg<Gxq< < < < << < < < << < < < < ”/!
.!Okjvbi<<<<!
.!Ofib<!fimz<!Ofib<!Lkz<!fimz<!< < < < << < < < << < < < < !
 
 “okiGg<gZx<x!nm<muqkh<!hiqm<js!ke<je< < < < < << < < < < << < < < < < !
Kzg<gLXl<!h{<ckOv!oktquigh<!< < < << < < << < < < !
Hgi<gqe<x!uii<k<jkjbh<!hii<!fijuh<h< < < < < < << < < < < < << < < < < < < iV!!
uGg<giqb!Okgole!okim<Mh<hiV< < << < << < < !
uelie!siQvk<kqe<!fqxk<jkh<hiVQ < < < <Q < < < <Q < < < < !
sgqg<gqiqb!lzk<jkh<!hiV!szk<jkh<hiV< < < < << < < < << < < < < !
sii<f<kuqpq!kjeh<!hii<k<K!oktquib<g<giO{< < < < < < << < < < < < << < < < < < < ”!
!!!!!!!! ! ! ! .g{<[silq!hvl<hjv!juk<kqbl<!hg<gl<< < < < < << < < < < << < < < < <.2!
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Envagai thervugal is the speciality of Siddha diagnosis. These are the instruments 
for the physician to diagnose disease. 
 
1. Naadi: 
 
The three Uyir thaadukkal felt through the pulse is called Naadi. 
 
Naadi    Vayu         Uyir thathu Ratio 
 
Edakalai  +  Abaanan  Vatham – 1 
 
Pinkalai  +  Piranan  Pitham – ½ 
 
Suzhumunai  +  Samanan  Kabam – ¼ 
 
 
“giqLgecjb!uip<k<kqg<< < << < << < <!
jgkeqz<!fic!hii<g<gqz<< < < << < < << < < <!
ohVuqvzr<!Gzk<kqz<< < << < << < <!
hqck<kc!fMOu!okim<miz<!< < << < << < < !
yV!uqvOzicz<!uikl<!< << << < !
dbi<!fMuqvzqz<!hqk<kl<< < < << < < << < < <!
sqVuqvz<!&e<xqOzicz<< < << < << < <!
sqOzk<Kl<!fic!kiOe< << << < ”!!
.ngk<kqbi<!fic< << << < !
.Ofib<!fimz<!Ofib<!Lkz<!fimz<!< < < < << < < < << < < < < !
2. Parisam: 
Observations by touch, temperature, sensory impairments, masses, nodes, 
swelling, and texture of the skin pain, hardness, oedematous, and dullness shall be 
noted. 
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3. Naa: 
Signs and symptoms in the tongue are considered here. Size, appearance, 
thickness, colour (pigmented, magenta) fissured (longitudinal, transverse) coated, 
geographical patches, oral hairy leucoplakia, candida, aphis ulcers, sense of taste, 
saliva secretion. 
4. Niram: 
The colour of skin is mainly considered here but also the change in other organs. 
 
In Swetha Kuttam, Niram was affected. 
 
5. Mozhi: 
The change in the normal sound of voice mainly urattha oli (Valithel), thazhltha 
oli (Melithal), physiological and mental status can also be noted during 
conversation. 
6. Vizhi 
Colour, warm, burning sensation, irritation, visual perception. 
 
7. Malam: 
Nature, quantity, colour, odour, froth, consistency are noted. 
 
8. Moothiram: 
The urine examination classified into two types 
a) Neerkkuri 
 
“uf<kfQi<!giq!wjm!l{l<!Fjv!wR<soze<< Q < < < << Q < < < << Q < < < <”!
.Okve<<<<!
.Ofib<!fimz<!Ofib<!Lk< < << < << < < z<fimz<< << << <!
!
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Urine is to be observed for the following characters 
 
Niram (colour) 
 
Edai (specific gravity) 
 
Manam (smell) 
 
Nurai (froth) 
 
Enjal (deposit) 
 
b) Neikkuri 
 
It is an important test to assess the predominantly affected humour. 
      
nVf<Kli!xqvkLl<!nuq< << << < Oviklklib<<<<!
n0gz<!nzi<kz<!ngizu,{<!kuqi<k<kpp<< < < < < < << < < < < < << < < < < < <!
Gx<xuVf<kq!dxr<gq!jugjx< < << < << < < ‘!
Ncg<gzsk<!kiuqOb!giKohb<!< < << < << < < !
okiV!l%i<k<kg<!gjzg<!Gm<hM!fQiqe<!< < < < < Q << < < < < Q << < < < < Q < !
fqxg<Gxq!ofx<Gxq!fqVlqk<kz<!gmOe< < < << < < << < < < !
.Okve<<<<!
.sqk<k!lVk<Kuir<g!SVg<gl<!)hg<gl<!w{<;!61:*< < < < < < < << < < < < < < << < < < < < < < !
 
On the day before the urine test one should take food, consisting of all the six 
tastes at the regular time based on one’s digestive fire; after a sound overnight 
sleep, urine should be collected in glass ward and the test should be done before 
90 minutes from dawn. 
 
A drop of oil is dropped at the centre of urine bowl without any shake. It should 
be ensured that the Sunlight falls on it, but is not disturbed by the wind. A keen 
observation of the oil drop suggests the condition of the patient. 
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If the oil drop takes the shape of a snake, it indicates Vatha disease. If it spreads 
like a ring it indicates Pitha and if it stands like a pearl it indicates Kapha disease. 
 
If there is a combined shape like a ring in a snake, or snake in the ring, snake and 
a pearl in the ring, it indicates combined derangement of humors. 
 
Swetha kuttam starts with disturbed Azhal and eventually involves all the three 
uyir thathus-thus resulting in various patterns of oil spread in the urine surface. 
 
NOI NEEKAM (TREATMENT) 
 
In siddha system the main aim of treatment is not only for the removal of physical 
illness but also the mental illness. Treatment is considered with prevention and 
improvement of the general body condition (rejuvenation) also. 
 
This is said as follows: 
 
Kappu/Thuvarppu  -  Prevention 
Neekkam  -  Treatment – curative 
Niraivu  -  Restoration – promotive 
 
While treating the disease the following principles must be noted. 
    
“Ofib<!fic!Ofib<!Lkz<fic!nK!k{qg<Gl<!< < < < << < < < << < < < < !
uib<fic!uib<h<hs<!osbz<< < < < << < < < << < < < <!
“dx<xietUl<!hq{qbtUr<!gizLr<< < < << < < << < < <!
gx<xie<!gVkqs<!osbz<< < < << < < << < < <”!
.kqVg<Gxt<< << << <!
 
 
So it is essential to diagnosis properly to know about the etiology, the nature of 
the patient, the severity of illness, the seasons and the time of the occurrence of 
the disease. 
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LINE OF TREATMENT: 
 
1. To bring the three Kutrams in equilibrium 
2. Medicines (Int & Ext) 
3. Diet and advises 
 
1. Bring the three Kutrams in Equilibrium: 
 
Since Siddha system of medicine is based of Mukkutra theory, the purgation 
(kalichal Maruthuvam) was given by for the vitiation of three humours. 
 
Agasthiyar Kuzhambu 100mg was administrated at early morning as a purgative 
in the prior day of treatment. 
 !
3/!lVf<Kgt<< << << <!
dt<lVf<K!!! ;!! h,uvS!hm<jm!GcfQi<!S,v{l<< Q < << Q < << Q < <!
ntU!! !!! ;!! 36gq!-VOujt!71lqzq 
HxlVf<K!!!! ;!! F{i!jkzl<<<< 
 
3. Diet and Advices 
Recommendations 
 
• Use Copper rich water storing it in a copper vessel for at least 8 hrs. 
• Increase green vegetables, carrot, bottle gourd, beans & pulses intake. 
• Consume soaked red grains 30-50gms / day as an immunomodulator. 
• Deworming is necessary in case worm’s infestation. 
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Restrictions 
(1) Citrus foods viz. Lemon, Orange, Grapes, Tomato, Pickles, Mango, 
Fine flour (Maida).  
(2) Butter milk(lassi), Apple, Chilli< Urad dal and food containing sour 
and Vitamin C contents. 
(3) Spicy, Salty Foods. 
(4) To avoid Curd, Oil, Alcohol, Sugar. 
(5) Mustard  
(6) Brinjal 
(7) Non-Vegetarian diet & fast foods. 
(8) Beverages like cold drinks. 
(9) Chemical based detergents/soaps.  
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MORDERN ASPECTS 
 
SKIN 
 
The Skin is one of the largest organ in the body.  It has many functions, the most 
important of which is as a barrier to protect the body from noxious external 
factors and keep the internal systems interact. 
 
Hippocrates, Father of Medicine described many skin diseases and divided them 
into two groups according to their exogenous or endogenous causes.  He 
attributed the origin of disease to abnormal mixing of black and yellow bile, blood 
and phlegm.  The theory of abnormally mixed humors played a major role in 
dermatology for a long time. 
 
Dermatology is a branch of medicine dealing with the skin.  Its roots reach back to 
antiquity.  The obviously manifested skin diseases have drawn the attention of 
men since time immemorial. 
 
Skin Anatomy: 
The human skin is the outer covering of the body and is continuous with the 
mucous membranes in the region of the mouth, nose, urogenitial organs and the 
anus.  In an adult the skin surface measures 1.5- 2m2 while the thickness of the 
skin varies from fractions of a millimeter to 4mm. The thickness of the epidermis 
varies from 0.006 – 0.9mm to 0.5-0.6mm. The thickness of the subcutaneous fat 
varies considerably.  Some areas are devoid of fat while in others (on the 
abdomen and gluteal regions), it is several centimeters thick.  The mass of skin of 
an adult accounts for approximately 5% while together with subcutaneous fat for 
about 10 to 17.7% of the total body mass. 
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Skin Histology: 
The skin develops from two germinative zones.  The ectoderm which is 
represented by the epidermis (the most superficial skin layer) and the mesoderm 
(the middle embryonal layer) represented by two layers namely the true skin, or 
dermis (the middle layer) and the subcutaneous fat or hypoderm the deepest skin 
layer. 
 
The boundary between the epidermis and dermis forms a wavy line because of the 
presence of skin papilla (special our growth on the surface of the true skin) the 
spaces between which are filled with epithelial processes). 
 
Layers of the skin: 
Skin is composed of three layers.  The epidermis, the dermis and the 
subcutaneous. 
 
 
  
  
  
  
  
  
 
 
 
 
Epiderms: 
The epidermis is defined as  a stratified squamous epithelium which is about 
0.1mm thick, although the thickness is greater (0.8-0.4mm) on the palm and sole.  
Its prime function is to act as a protective barrier. The main cell of the epidermis 
is the keratinocyte which  produces the protein keratin.  
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The four layers the epidermis represent the stages of maturation of keratin by 
keratinocytes. 
1. Basal Cell layer (Stratum basale) 
2. Prickle cell layer (Stratum spinosum) 
3. Granular cell layer (Stratum granulosum) 
4. Horny layer (Stratum corneum) 
 
Dermis: 
The dermis is defined as a tough supportive connective tissue matrix, containing, 
specialized structures, found immediately below and intimately connected with 
the epidermis. Two layers are distinguished in it, the papillary or sub epithelial 
layers and the reticular layer.  The papillary layer is that part of the dermis which 
is found between the epidermis and the superficial network of blood vessels. The 
reticular layer merges with the subcutaneous fat and is not demarcated from it 
sharply.  The dermis is supportive connective tissue, mainly collagen, elastin and 
glycosaminoglycans. 
 
Subcutaneous Layer: 
The subcutis consists of loose connective tissue and fat (upto 3 cm thick on the 
abdomen). 
 
Blood and Lymphatic Vessels: 
The skin also has a rich and adaptive blood supply.  Arteries in the subcuits 
branch upwards, forming a superficial plexus at the papillary/reticular dermal 
boundary.  Branches extend to the dermal papillae, each of which has a single 
loop of capillary vessels, one arterial and one venous.  Veins drain from the 
venous side of the loop to form the mid-dermal and subcutaneous venous 
networks.  In the reticular and papillary dermis there are arteriovenous 
anastomoses which are well innervated and concerned with thermoregulation. 
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The lymphatic drainage of the skin is important, and abundant meshes of 
lymphatics originate in the papillae and assemble into larger vessels which 
ultimately drain into the regional lymph nodes. 
 
Pigmentation of the Skin: 
The colour of the skin may be brown or even black according to the amount of 
pigment present and it varies due to external and internal factors. 
 
Even in white races most parts of the skin contain brown pigment granules in the 
deepest layers of the germinative zone of the epidermis. In dark races they are 
more abundant and extend throughout the whole zone. 
 
The degree of racial pigmentation does not depend on the number of melanocytes 
present but on their metabolic activity and the size and shape of their melanin 
producing organelles the melanosomes. 
 
Brownness of the skin depends upon transfer of melanosomes from melanocytes 
into keratinocytes.  Melanosomes are cytoplasmic particle fromed in melanocyted 
and then distributed among the basal cells of the epidermis. Each melanocytes in 
the epidermis secretes melaosomes are the site of melanin synthesis by the action 
of tyrosinase upon tyrosine. 
 
Melanin: 
Melanin – Derived from the Greek word Melas, meaning black. 
Melanin is complex black –brown polymer synthesized from the amino acid 
dihydroxyphenyl alanine (L-DOPA). 
 
The forms of melanin exist. 
• Ordinary melanin known as eumelanin and a melanin synthesized from 
cysteiny1 DOPA with a more reddish hue, known as phaeomelanin. 
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The initial part of melanin synthesis is catalysed by a copper –containing enzyme 
complex known as tyrosinase which also catalyses the transformation of L.DOPA 
to tyrosine. 
 
Melanin Formation: 
Melanin, wherever it is found, is formed in the local cells by the enzyme 
tyrosinase (or) melanase. The mother substance, upon which the enzyme acts, is a 
tyrosine derivative (DOPA) believed to be formed in the adrenals. Melanin 
synthesis from the oxidation of phenylalanine or tyrosine is as follows: 
 
1. Tyrosine  → DOPA → DOPA → Quinone 
2. DOPA –Quinon → 2-Carboxy 2.3 – dihydro – 5.6 – dihyroxyindole. 
→2-Carboxy – 2.3 – dihydro – indole – 5.6 – Quinone → 5.6 
Dihydroxyindole. 
3. 5.6 Dihydroxyindole → Indole -5.6 Quinone → Melanin 
Melanin formatioin in both human and amphibian skin is augmented by the 
Hormone known as intermedian or melanocyle – stimulating hormone (MSH) 
secreted by the pars intermedian of the pituitary gland. Adrenocarticotropic 
hormone (ACTH) secreted by anterior Pituitary has melanocytestimulating 
activity similar to MSH although to a much lower degree. In Addison’s disease 
ACTH is secreted in a large amount and there is brownish black pigmentation of 
the exposed parts of the skin Eg. Hands, feet and mucous membrane. 
 
Melatonin extract from bovine pineal gland, causes concentration of melanin near 
the nuclei of melanocytes in frog and as a result of this the skin becomes pale.  Its 
role in the human is not known. MSH causes the serum copper to rise and this is 
accompanied by in the melanin formation. Diminished formation of melanin is 
seen in albinism and leucoderms.  In melanotic sarcoma, melanin may be found in 
the urine. 
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Distribution: 
It is widely distributed in the body but peculiarly enough it is limited only to those 
structures which have got an ectodermal origin, for Eg: skin, hair, choroid coat of 
retina and substantia nigra of the brain. 
 
Functions: 
The function of melanin in the choroids is namely to covert the eye ball into a 
perfect dark chamber. Since nervous tissue is derived from ectoderm, the melanin 
in the substantia nigra may represent the vestigial remnants of the melanin in the 
substantia nigra may represent the vestigial remnants of the melanin forming 
properties.  Melanin is the great protector of the skin against the actinic rays of the 
sun. 
 
Melanin in keratinocyges is black and absorbs all visible light, UVR and infrared 
radiation. It is also a powerful electron acceptor and may have other protective 
functions which as yet have been poorly characterized. 
 
Abnormal Pigmentation 
Normal pigmentation of the skin is influenced of the amount and depth of 
melanin, by the degree of vascularity, by the presence of carotene and by the 
thickness of the horny layer.  The amount of melanin produced is influenced by 
genetic factors, the amount and wave lengths of UV light received the amount of 
melanocyte.  Stimulating hormone (MSH) secreted, and the effected of 
melanocyte stimulating chemical such as furocoumarins (psoralens) Abnormal 
pigmentation of the skin is produced by a variety of causes. 
 
Types of pigmentary disorder: 
Excessive pigmentation is known as hyper pigmentation and decreased 
pigmentation is known as hypo pigmentation.  Both may be localized or 
generalized. In addition, increased pigmentation may result from deposits of 
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abnormal non melanin pigments in the skin, Eg, Haemosiderin from broken down 
haem pigment in extravasated blood. 
 
Homogentisic acid deposited in cartilage particular in the inherited metabolic 
defect known s alkaptonuria. 
 
Drugs and heavy metals toxicity. Silver, Gold, Mercury, Arsenic poisoning, 
Amiodarone and phenothiazines causes slate grey, dusky skin pigmentation in 
exposed sites. 
 
Vitiligo: 
The name ‘Vitiligo’ is derived from the Latin work skin eruption, victim meaning 
a blemish (spoil the beauty of) happens to be a synonym for it.  White skin is the 
literal meaning of leucoderma, derma being derived from the Greek words, leucas 
and dermis.  Leucas means white and dermis mans skin. 
 
Celeus was the first Roman physician of the 2nd century to coin the word vitiligo, 
because the disease resembles the white patches of a spotted calf (vitelus). 
 
Being a social problem.  WHO announced May 19th as “World Vitiligo day” to 
create awareness. 
 
Prevalence: 
About 0.5 to 1 percent of the world’s populations, or as many as 65 million 
people, have vitiligo.  In the United States, 1 to 2 million people has the disorder. 
Half the people who have vitiligo develop it before age 20; most develop in before 
their 40th birthday.  The disorder affects both sexes and all races equally; however, 
it is more noticeable in people with dark skin. 
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Epidemiology: 
Vitiligo is an acquired idiopathic depigmentary condition which, though 
worldwide in distribution, is most common in India.  Egypt and other tropical 
countries. It is a source of great social embarrassment of dark skinned people.  It 
affects all age groups with no predilection to either sex. 
 
Gross Anatomical changes in Vitiligo: 
Vitiligo represents an acquired patchy loss of pigments of the skin.  There are no 
gross changes seen except irregularly demarcated. Hypo pigmented patches of 
varying size, usually surrounded by hyper pigmented skin.  These are seen 
distribute symmetrically or asymmetrically at various parts of the body. 
 
1. Definition: 
 Vitiligo is an acquired often disfiguring, pigmentary anomaly of the skin 
manifested by depigmented white patches surrounded by a normal or a 
hyperpigmented border. 
 
 As a result, white patches appear on the skin in different parts of the body. 
similar patches also appear on both the mucous membranes ( tissues that line the 
inside of the month and nose), and the retina (inner layer of the eyeball).  The hair 
that grows on areas affected by vitiligo sometimes turns white. 
 
 It is an extremely common depigmentary disorder of great medicosocial 
significance among the dark people, etiology is uncertain association with 
variable penetrance; a symptomatic puncture linear, oval, circular or irregular, 
discrete or confluent depigmented and or hypopigmented macules on otherwise 
normal skin is confined to mucocutaneous functions dermatomal unilateral or 
bilateral, symmetrical or asymmetrical generalized or universal over laying hair 
retain pigment or turn white, no autonomic or sensory disturbances, sun burn or 
chronic solar damage in longstanding cases, impredictable and capricious course, 
stationary, self healing or progressive. 
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 It is quite clear that vitiligo is due to some derangement in the pigment 
metabolism resulting in appearance of white patches in the skin. It is hard to say 
whether the site of derangement is usually general or local, but the main affected 
part is the skin, which is the most exposed part of the body. It can be examined by 
naked eye and can furnish a lot of information about the person and the disease.  
In certain cases the changes are not clear. Hence the study of the skin structure 
and its physiology is essentials for proper assessment. 
 
II. Etiology & Pathogenesis: 
• Epidemiological studies suggest that vitiligo or a susceptibility to the 
disease may be inherited and about one fourth to one third of patients have 
family members affected with the disease.  A multifactorial pattern of 
inheritance is revealed is most studies. 
• Three possible mechanisms that may cause destruction of melanocytes, the 
pigment – producing cells of the skin, have been suggested by different 
workers. 
• The autoimmune hypothesis originated from the observation that vitiligo 
is associated with some autoimmune diseases. Both cellular and humoral 
factors responsible for autoimmune damage to melanocytes have been 
demonstrated. 
 
These autoimmune disease include hyperthyroidism (an overactive thyroid gland), 
adrenocortical insufficiency (the adrenal gland does not produce enough of the 
hormone called corticosteroid), alopecia areata (patches of baldness), and 
pernicious anemia (a low level of red blood cells caused by the failure of the body 
to absorb vitamin B12), and it is also common in diabetes mellitus. 
 
Scientists do not know the reason for the association between vitiligo and these 
autoimmune diseases. However, most people with vitiligo have no other 
autoimmune disease. 
41 
 
• The autocytotoxic  or self – destruct hypothesis suggests that some toxic 
molecules produced during the biosynthesis of melanin are responsible for 
melanocyte damage is susceptible inviduals. 
• The neural hypothesis postulates that neurochemicals liberated from nerve 
endings are toxic to melanocytes. 
Drugs and chemicals – like quinines, guano furacin, amylphenol, chlorthiazide, 
board spectrum antibiotics and chloroquin. 
 
It is also regarded to develop through eczema scar of prick by injection needle, 
injury by burn or from other accidents, by friction of foot, wearing tight clothes.  
It has also been observed in persons who have suffered serious illness due to 
typhoid, jaundice, liver diseases, diabetes, worms, constipation and diarrhea. 
 
The non pigmented patches whitish or reddish are round or oval in shape with 
smooth surface and slowly grow into large, irregularly outline areas.  It may be 
the result of skin disease or it may be harmless conditions of unknown cause. 
 
• Hereditary factors 
Hereditary is one of the factors supposed to be related with venpadi 
Familial incidence has been reported in 7.5 to 21% in India and 33 to 40% 
in Western countries. 
 
• Emotional factors 
It is every day knowledge and observation that emotional factors affect the 
skin as shown by the blushing of embracement, the pallor of fear and the 
pallor or redness of change, depending on the subject and his emotional 
state. Experiments have demonstrated that emotional change can affect the 
following, which has direct relevance in the etiology of certain skin 
disorders. 
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- Control of vascularity of the skin 
- Control of sebaceous gland secretion 
- Influencing the degree of oxidation. 
- Influencing the tendency of pruritus. 
There is due to the causative factor of this disease, venpadai from the following 
basic facts, it is generally considered to be a trophoneurosis. Psychological factors 
are known to be responsible for the precipitation and aggravation of the disease. 
 
• Others 
Sometimes vitiligo can be caused by the action of monobenzyle either on 
hydroquinone presents in the slippers, gloves (or) other articles made of 
rubber or used as a depigmenting agent in the form of an irritant for 
pigmentary disorders. Recently vitiligo has also been observed to occur 
from plastic slippers as well as plastic ‘hindis’. 
 
III Pathology: 
 Chemically melanin pigment is a group of chromo proteins with coloured 
prosthetic groups, which is derived from the precursor tyrosine in the following 
way Tyrosine tyrinase dihydroxy phenylanin (DOPA) Melanogenase Melanin 
(Dopa Oxidase). 
 Melanin + Protein = Melano protein 
 
The possible pathogenetic mechanism, a schematic picture of the causal and 
temporal sequence leading to the melanocyte functional impairment during 
vitiligo. 
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In the skin, the pigment is produced by the melanocytes of their procursor’s 
melanoblasts.  The melanoblasts are supposed to be derived from the cells of 
neuro ectodermal origin during the embryonic life.  After birth, these cells migrate 
to their definitive position. The melanocytes appear as clear cells within the basal 
cell layer of the epidemis and show dendritic processes after special staining.  
These processes come in contact with similar process of other melanocytes and 
epithelial cells through which the melanin pigments are donated to the basal cells 
of epidermis. The dermis of normal skin also shows macrophages containing 
melanin pigments known as melanophores, which are incapable to produce the 
melanin pigments. 
 
Histopathalogic changes in vitiligo: 
Marked histological changes do not occur  in cases of Vitiligo.  All the layers of 
the epidermis and dermis appear normal except a few changes which can be seen 
after special stains. 
 
In the affected area the basal cells and the keratinizing cells of the other layers of 
epidermis do not contain melanin pigment granules in them. The contrast can be 
seen at a junction of the normal and vitiligenous areas of the skin, especially by 
silver staining or DOPA reaction. The pigment cells, the melanocytes are not seen 
in the affected area but they are present in the adjacent normal skin. At the border 
of the patches of vitiligo the melanocytes often appear large and posse’s long 
dendritic process filled with melanin granules.  Electron microscopic studies 
confirm the absence of melanocytes in areas of long standing vitiligo. 
 
There are collections of mononuclear cells at dermo epidermal junction at the 
border between vitisliginous and normal skin.  These cells are predominately 
small lymphocytes.  In the long standing case where the skin has become thick 
and scaly, varying amount of the keratosis is seen. 
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IV. Clinical Features: 
• Vitiligo affects all races with an average frequency of 1 to 2 percent of the 
population. Both sexes are affected equally and the disease may develop at 
any age.  The peak age of on set in most series was between 10 and 30 
years. Stressful life events or physical trauma can often precipitate the 
onset of disease. 
• The typical macule of vitiligo is easily recognized by well circumscribed 
milky white spots of varying sizes without any other discernable surface 
change of the skin.  The hairs on the patch may turn gray or white 
(Leucotrichia). There may be a single spot or numerous white macules 
distributed all over the body. with passage of time, the macules may 
enlarge and coalesce to produce extensive pigment loss.  The lesions are 
symptomless. 
• Occasionally the depigmented areas are slightly pink at the start of the 
disorder. 
• Often the depigmented patches are symmetrical, especially when the 
disorder is distributed over the peripheral parts of the limbs and the face. 
• These patches are more commonly found on sun-exposed areas of the 
body, including the hands, feet, arms, face, and lips. Other common areas 
for white patches to appear are the armpits and groin, and around the 
mouth, eyes, nostrils, navel, genitals, and rectal areas. 
• In addition to white patches on the skin, people with vitiligo may have 
premature graying of the scalp hair, eyelashes, eyebrows, and beard. 
People with dark skin may notice a loss of colour inside the mouths. 
• Odd patterns are sometimes noted as for example, when the 
depigmentation occurs over the front of the neck over the thyroid gland, or 
on the abdomen over the site of the pancreas or on the flanks over the sites 
of the adrenal glands. 
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• Vitiligo lesions may result from ‘Koebner phenomenon’ i.e. appearance of 
new lesions at sites of non-specific trauma such as abrasion, surgical scars, 
severe sunburn or inflammatory skin diseases like psoriasis or eczema. 
• Vitiligo is most noticeable in the summer when the normal skin is tanned 
by the sun. 
• Vitiligo sometimes disappears spontaneously after months or years but 
more usually the conditions spreads slowly and may eventually involve 
nearly whole of the skin. 
• Early lesions may be pale white and ill defined. At this stage, Wood’s lamp 
helps to confirm the diagnosis. Patches enlarge slowly and may affect the 
whole body. 
 
V. Types: 
* According to the extent of involvement and pattern of distribution, 
vitiligo is clinically categorized into focal, segmental, generalized, 
acrofacial, and universal types. 
* Focal Vitiligo  is and isolated macule or a few macules in a 
localized non-dermatomal distribution. 
* Segmental vitiligo is characterized by macules in a unilateral 
dermatomal distribution. This type of disease usually pursues a 
stable course. 
* Generalised vitiligo is the most common type showing macules in a 
generalized widespread distribution. There is often striking 
symmetry of affection and involvement of extensor surfaces. Face 
(particularly around the orifices), neck, bony prominences of hands, 
legs: axilla and mucosal surfaces are particularly affected. 
* Acrofacial vitiligo affects distal end of fingers and facial orificies in 
circumferential pattern. 
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* Universal vitiligo implies loss of pigment over the entire body 
surface areith only isolated islands of normal pigmentation 
remaining. 
 
VI Associated diseases: 
* Patients with vitiligo have in increased risk of developing 
autoimmune diseases like thyroid diseases, Addison’s disease, 
pernicious anemia and insulin-dependent diabetes mellitus. Auto 
antibodies against other organs may be detected in the absence of 
clinical evidence of the disease.  Premature graying of hair and 
alopecia areata are important cutaneous associations in some 
patients. 
* The pigment epithelium of retina and choroid are developmentally 
derived from the neural crest, the cutaneous melanocytes originate 
from the same embryonic structure.  They ma share the 
susceptibility to damage in vitiligo; iris and retinal pigmentary 
anomalies in the absence of ophthalmologic complaints may be 
detected in a proportion of the patients. Iris may be found in a small 
number of patients. 
 
Psychosocial Impact of Vitiligo 
* Althogh vitiligo by itself is symptomatic and does not cause any 
physical discomfort or disability, it may be associated with 
devastating psychological and social consequences. Since a person’s 
appearance is a major determinant of his/her personality traits, 
vitiligo, by causing cosmetic blemishes can have major impact on 
personality. 
* Feeling of stress and embarrassment on social contacts, lack of 
confidence and lowered self esteem may be detrimental to the 
patients, particularly when the spots are a visible area of the body. 
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* The psychological impact can have serious implications in deeply 
pigmented races such as Indians, in whom the contrast between the 
normally dark skin and the white lesions can be marked. 
 
Clinical Criteria for Classification of Vitiligo: 
Stages of Clinical Features: 
Vitiligo   
Active (V1) (i) New lesions developing  
 
(ii) Lesions increasing in size. 
 
(iii) Border ill-defined 
Quiescent (V2) (i) No new lesions developing 
 
(ii) Lesions stationary in size  
 
(iii) Border hyper pigmented and well defined. 
Improving (V3) (i) Lesions decreasing in size 
 
(ii) No new lesions developing 
 
(iii) Border defined and signs of spontaneous 
regimentation 
 
Zosteriform: Unilateral distribution of lesions, preferably along the course of 
nerves. Besides typing the stage of disease, it is useful to decide the variety (acral, 
vulgaris, zosteriform), Severity (Localized or extensive) and acuity (insidious or 
galloping) or vitiligo. 
 
VII Diagnosis: 
• The diagnosis of vitiligo is made based on a physical examination medical 
history, and laboratory tests. 
• Physical examination: White patches of skin on the body particularly 
on sun-exposed areas, including the hands, feet, arms, face and lips. 
• Medical History: Important factors in the diagnosis include a family 
history of vitiligo; a rash, sunburn, or other skin trauma at the site of 
vitiligo 2 to 3 months before depigmentation started; stress or physical 
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illness; and premature (before age 35)  graying of the hair and ask whether 
patient or anyone his family has had any autoimmune disease, and whether 
patients are very sensitive to the sun. 
• Laboratory tests: To help confirm the diagnosis, we make take a small 
sample (biopsy) of the affected skin to examine under a microscope.  In 
vitiligo, the skin sample will usually show a complete absence of pigment 
–producing melanocytes. On the other hand, the presence of inflamed cells 
in the sample may suggest that another condition is responsible for the loss 
of pigmentation. 
• It is usually apparent; in doubtful and early case. Wood’s lamp is of great 
help in diagnosis. 
• These areas often fluorescence a golden yellow when examined under a 
Wood’s lamp.  The hypomelanotic macules in leprosy are anesthetic. 
• Examination of the skin in long wave UVR helps distinguish whether there 
is total depigmentation (as in vitiligo) or not. it may also detect areas of 
depigmentation not easily seen in ordinary daylight, as well as detecting a 
lemon-yellow fluorescence seen in some cases of pityriasis versicolour. 
 
VIII Course and prognosis: 
• The common generalized vitiligo usually pursues a course of slow 
progression with enlargement of existing macules and gradual appearance 
of fresh spots. Quite often, after an initial phase of progression, the lesions 
remain relatively stable for varying periods of time only to be followed by 
accelerated spread, sometimes there may be very rapid spread leading to 
extensive loss of pigmentation within a short span of time. In an individual 
case the course however is unpredictable. 
• In comparison with the aforesaid, segmental vitiligo tends to have a very 
stable course. Following appearance of lesions in a dermatomal 
distribution, the lesions usually remain localized to the area of affection. 
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• Spontaneous regimentation may be observed in a proportion of patients 
particularly in lesions on sun-exposed areas.  However, the extent of 
spontaneous healing is seldom cosmetically significant. 
 
It has improved considerably in recent years because of better understanding of 
etiological factors and advances made in therapy. Following conditions are said to 
be of poor prognosis. 
(i) Poor nutritional state or digestion, use of broad – spectrum antibiotics over 
log period.  Emotional stress and nervous debility. 
(ii) Presence of vitiligo on resistant sites like the hands and the feet, front of 
wrists, the elbow, the waist, the eyelids and lips. 
 (iii) Depigmented hair in vitiliginous areas. 
 
Other Causes of Hypo Pigmentation: 
Generalised depigmentation is found mostly in albinos. In this case, the 
characteristic dendritic melanocytes are present in the skin, but they are unable to 
produce melanin pigment due to defective tyrosinase activity. In albinism, the 
skin looks milky white, the hairs are pale looking and the iris is transparent.  The 
generalized pallor is also noticed in panhypopituitiarism, male eunuchoidism and 
phenyl ketouria. 
 
Located depigmentatioin is often noticed in the skin of pattern leucoderma. The 
white patches on the skin may be quite extensive and the condition is inherited as 
an autosomal dominant character. 
 
Sometimes sharply defined focal depigmented areas are found on skin of persons 
suffering from vitiligo. In the affected areas, melanocytes are absent and there is 
no trace of melanin.  The condition is an acquired one and shows some familial 
tendency. 
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Leucoderma: 
Leucoderma may be defined as a type of acquired skin dipigmentation produced 
by some specific substances (or) dermatosis several types of Leucoderma may be 
seen. 
 
1. Occupational Leucoderma may occur in those who work in rubber 
garments (or) wear gloves that contain antioxidant monobenzyl ether of 
hydroguinone many phenolic compounds can produces Leucoderma. 
2. Postinflammatory Leucoderma may result from many inflammatory 
dermatoses such are, Pityriasis rosea, psoriasis, herpes zoster, secondary 
syphilis, and morphea. 
 
Leucoderma is also commonly seen on the flanks of ladies wearing tight petticoat 
strings where the prolonged pressure is presumed to lead to depigmentation. 
 
Piebaldism: 
In this condition there is a white forelock and white patches on the skin surface.  
In waardenburgs syndrome the condition associated with sensory deafness. 
Pityriasis Versicolour Superficial fungus infection leading to disturbance 
in pigment production, common multiple pale 
scaling patches on trunk. 
Pityrisis alba Mild patchy eczema of the face in children causing 
a disturbance in pigment production. 
Leprosy One or several paler macules on trunk or limbs that 
are hypo aesthetic. 
White macules of affecting 
tuberous sclerosis 
Uncoming development of anomaly of CNS, 
connective tissue and skin; several ‘maple leaf’ 
shaped hypopigmented macules. 
Postinflammatory 
hypopigmentation  
After inflammatory skin disease (after eczema or 
trauma to the skin, irregular in shape and in depth 
of pallor). 
Naevous annemicus Rare developmental solitary white patch usually on 
trunk; thought to have vascular basis. 
Chemical toxicity May look very much like vitiligo; seen in workers 
in rubber industry exposed to parateriary 
benzyltoluence. 
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DIFFERENTIAL DIAGNOSIS OF THE IMPORTANT DEPIGMENTARY 
DISORDERS. 
 
Distinguish 
feactures 
Albinism Naevus 
dpigmentosus 
Vitiligo Leprosy Pityriasis 
Age Congenital 
present at 
birth 
Congenital 
present at 
birth 
Acquired Any age Any age 
Distribution Complete 
(or) Partial 
Unilateral Any area Any area Trunk, Neck, 
and Face. 
Course Stationary Does not 
increase in 
size or 
changing 
shape 
Progressive Progressive Progressive 
worse in 
mansoon and 
summer 
Hyperpigmentary 
border 
Nil Nil Present Inflammatory Nil 
Heredofamilial Hereditary Not hereditary Rare Nil Nil 
Other features Hair and 
eyes may be 
affected 
Nil Hair may be 
affected 
Anesthesia 
thickened 
nerves, nasal, 
bleeding slit 
smear and 
biopsy 
Furfuraceous 
like dandruff, 
scaling in 
head macules 
and large 
patches. 
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TRIAL DRUGS 
LITERATURE REVIEW OF TRIAL DRUGS 
 
1) ótuR -  Puvarasu 
 
 Botanical name : Thespesia populnea.Linn.soland 
 Family  : Malvaceae 
 ntW bga®  : òéuhr‹, ód« 
 Rit   : if¥ò, Jt®¥ò 
 j‹ik  : bt¥g« 
 ÃçÎ   : fh®¥ò 
 brŒif  : òG¡bfhšè 
     JhŒikah¡» 
  
Fz« : 
 
``Eh‰wh©L br‹wbjhU Eh©ó tur«nt® 
Ehwh©l F£il¤ bjhiy¡F§fh©-Å¿¥ 
gG¤jÏiy éijó¥g£ilæit f©lh‰ 
òG¤j ò©é nurdK« ngh«.. 
 
F£l§ foNiy bfhšY« élghf¤ 
J£l knfhjuKŠ nrhigbahL- »£obkæš 
jhÎfu¥ gh‹»uªÂ j©nkf« ngh¡»éL« 
ótur§ fhŒ¥ g£il¥ ó`` 
 
-Fzghl« Kjš ghf« g¡f« v© 705 
 
 
- F£l«, foNiy, élghf«, knfhju«, nrhig,fu¥gh‹, »uªÂ,nkf« nghF«. 
 
 
 
 
2. Ezh 
 
Botanical name : Morinda tinctoria 
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ntWbga®  : kŠrz¤Â, kŠrzh¤Â, 
    jz¡F, EzÎ 
Rit   : fh®¥ò 
j‹ik  : bt¥g« 
ÃçÎ   : fh®¥ò 
brŒif  : Å¡fKU¡» 
Ïiy,fhŒ  : UJÎ©lh¡» 
gH«   : cuK©lh¡» 
    bt¥gf‰¿ 
    bt¥gK©lh¡» 
nt®   : bgUky«ngh¡» 
bghJFz«  :  
 
g£il fu¥gbdhL ghu¢Á nyZkRu« 
x£o ã‹¿ ò©»uªÂ x£L§fh©-k£lyiu 
VªJ Ezhé‹ Ïiykªj« Ô®¤Ješy 
fhªÂjU nkfkL§ fh© 
     -Fz¥ghl« Kjš ghf« - g¡f« v© 590 
 
fu¥gh‹, IaRu«, ò©, fHiy, khªj«,nkf« Ïitfis xê¡F« , clš xëia¤ jU« 
 
3. ešby©zŒ (vŸë‹ beŒ) 
 
Gingelly oil 
 
brŒif:  cŸsHyh‰¿ 
  kyäs¡» 
  clYukh¡» 
  tw£Áaf‰¿ 
 
Fz« 
 
ò¤Âead¡Fë®¢Á óç¥ò bkŒ¥òsfŠ 
r¤Jt§ fªÂ jåæsik-bk¤jÎ©lh§ 
f©nzhŒ brénehŒ fghytHš fhrnehŒ 
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ò©nzhŒ ngh bk©bzŒah‰ ngh‰W 
     -Fzghl« Kjš ghf« -g¡f« v© 164 
 
 
ò¤Â bjëÎ, éêfS¡F Fë®¢Á 
clš óç¥ò, clš t‹ik M»at‰iw¤ 
jUtnjhL,f©nzhŒ,fhJnehŒ, jiy¡bfhÂ¥ò 
brh¿, Áu§F, ò© KjèaitfisÍ« ngh¡F«. 
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TRIAL MEDICINES 
 
1. ótur«  g£il FoÚ® Nuz« :- 
 F£l§ foNiy bfhšY« élghf¤ 
 J£l knfhjuKŠ nrhigbahL-»£obkæš 
 jhÎfu¥ gh‹»uªÂ j©nkf« ngh¡»éL« 
 ótur§ fhŒ¥g£il¥ ó 
     --Fzghl« Kjš ghf« g¡f« v© 705 
 
ÁW J©Lfshf bt£oa g£il 210 »uh« j©Ù® 1400 ä.è é£L¡ fhŒ¢Á _‹¿š 
x‹whŒ t‰¿a Ã‹ tof£o vL¤J¡ bfhŸsš 
 
   msÎ  60 ml ÏUntis 
 
2.  Ezh ijy«:- 
 brŒKiw 
Ezh Ïiy f‰f«, ešby©bzŒ Xbuil nr®¤J fhŒ¢Á, fLF Âus to¤J¡ 
bfhŸsÎ«. 
 
 Ãunahf«:-  btëÃunahf« 
 ÔU«nehŒ:-  bt©òŸë Ú§F«. 
     --Fzghl« Kjš ghf« g¡f« v© 591 
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MATERIALS AND METHODS 
 
The clinical study of Swatha Kuttam was carried out in post graduate department 
of Maruthuvam, Govt. Siddha Medical College, attached to Arignar Anna 
Hospital, Arumbakkam, Chennai – 600 106. 
 
Selection of Cases: 
The population consists of all patients with Swatha Kuttam (completely 
depigmented or hypopigmented patches without any structural change in the skin) 
satisfying the inclusion and exclusion criteria mentioned below. 
 
Sample Size: 
The trial size will be 40 patients. (Both Male and Female) 
 
Data Collections: 
Literary evidence collected from various 
• Siddha Literature  
• Books on Modern medicines 
• Medical Journals 
• Internet 
 
Inclusion Criteria: 
1. Age between 10 to 55 years. 
2. Willing to give specimen of blood for investigation when required. 
3. Willing to attend OPD once in 15 days for 3 months. 
4. Hypoopigmental patches 
5. Patient having white or pink coloured patches 
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Exclusion Criteria: 
1. Patients of Jaundice 
2. Hypopigmented patches of leprosy and burns 
3. Connective tissue disorders. 
4. Heart ailments are not eligible for this trial 
5. Fungal infection 
6. Worm infestation 
 
Withdrawal Criteria: 
1. Any drastic changes occurring in hematological findings during treatment 
period. 
2. Development of any exacerbation in clinical features. 
 
Trial Period: 
- 3 Months 
Evaluation of Clinical Parameters: 
Clinical Assessment 
 Site 
 Size 
 Colour 
 Margin 
 Shape 
 Itching. 
 
Investigations: 
Blood Test : RBC, Hb, Tc, Dc, ESR, Blood Sugar 
   Serum Cholesterol, Blood Urea. 
Urine Test : Albumin, Sugar, Deposit, Serum Creatinine 
Motion Test : Ova,  Cyst 
 
Siddha Aspects: 
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1. Envagai Thervu 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Sparism 
 Naadi 
 Malam 
 Moothiram 
 
2. Neerkuri 
 Niram 
 Manam 
 Nurai 
 Enjal 
 Eadai 
 
3. Neikuri 
 Conduction of the study 
 Swatha Kuttam patients satisfying the inclusion and exclusion criteria will 
be included in the trial.  Informed consent will be obtained from the patients.  A 
day before starting the trial treatment, cleaning of mukkutram by purgation will be 
carried out by Agasthiyar Kuzhambu, early morning 100mg with hot water. 
 
 For O.P. patients, the trial drugs will be issued for 7 days at a time. They 
will be asked to attend the O.P. department once in 7 days. 
 
Case Sheet Proforma: 
All clinical signs and symptoms of “Swatha Kuttam” history of the present and 
the past illness, personal history, family history, habits and occupation were 
recorded.  Lab investigation and prognosis were recorded for analysis. 
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Trial Drug, Dosage: 
The following medicine were selected on the basis of Siddha Literature and given. 
 
1. Puvarasam Pattai Kudineer Choornam 25 gm – 60ml twice a day - Internal  
2. Nuna Thylam - External 
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RESULTS AND OBSERVATION 
 
 A Total number of 40 patients were treated in O.P of PG Maruthuvam 
Department attached with Arignar Anna Govt., Hospital of Indian Medicine 
during the period 2010-2012. All patients  included in the study with signs and 
symptoms of Swetha kuttam were observed. The observations were tabulated 
regarding the following features. 
 AGE REFERENCE 
 RELIGION REFERENCE 
 SEX REFERENCE 
 SOCIO ECONOMIC STATUS 
 ETIOLOGY REFERENCE 
 DIET REFERENCE 
 FAMILY HISTORY REFERENCE 
 THINAI 
 SITE OF LESION 
 PARUVA KAALAM 
 DERANGEMENT IN THE TYPES OF VAATHAM, PITHAM, 
KABHAM 
 UDAL KATTUGAL 
 ENVAGAI THERVU 
 DISTRIBUTION OF NAADI AMONG THE PATIENT WITH SWETHA 
KUTTAM 
 NEIKURI REFERENCE 
 CLINICAL FEATURES BEFORE & AFTER TREATMENT 
 GRADATION OF RESULTS 
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AGE REFERENCE 
 
Age  
(In Years) No. of Cases 40 Percentage % 
10-30 12 30.0 
30-40 5 12.5 
40-55 23 57.5 
 
 
 
Inference  
About 57.5% of them were aged 40-55 years and 12.5% cases 30-40 
years, 30% cases 10-30 years. 
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SEX REFERENCE 
 
Sex No. of Cases Out of 40 Percentage % 
Male 26 65 
Female 14 35 
 
 
 
Inference  
65% were Male cases and 35% were Female cases. 
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RELIGION REFERENCE 
 
Religion No.of Cases Out of 40 Percentage % 
Hindu 37 92.5 
Christian 2 5 
Muslim 1 2.5 
 
 
 
 
Inference  
Most of the patient’s religion Hindu 92.5%, Christian 5% and 
Muslims 2.5%   
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SOCIO ECONOMIC STATUS 
 
Socio Economic Status No.of Cases  Out of 40 Percentage% 
Low Income Group  
(Below Rs.10000) 15 37.5% 
Middle Income Group 
(Rs.10001 – Rs.20000) 21 52.5% 
High Income Group 
(Above Rs.20000) 4 10% 
 
 
 
Inference  
About 52.5% of the patients were middle income group, 37.5% lower 
and 10% high income group. 
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ETIOLOGY REFERENCE 
 
Etiology No.of Cases  
Out of 40 
Percentage % 
Hereditary 3 7.5% 
Autoimmune diseases 4 10% 
Unknown 33 82.5% 
Worm Infestation 0 0 
 
 
 
 
Figure 1 
Inference  
About 50% of the cases were 7.5% Hereditary, 10%  Autoimmune 
diseases,  82.5% Unknown Etiology.  
 
 
10%
7.5%
Hereditary
Autoimmune Diseases
Unknown
ETIOLOGY REFERENCE
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DIET REFERENCE 
 
Food Habits No.of cases  
out of 40 Percentage % 
Vegetarian 12 30% 
Mixed Diet 28 70% 
 
 
 
Inference  
70% of cases were taken mixed diet. 
30% of cases were taken Vegetarian. 
 
 
 
4 
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THINAI 
 
Thinai 
 
No.of Cases 
Out of 40 
Percentage% 
Kurinji 4 10% 
Mullai 2 5% 
Marutham 5 12.5% 
Neithal 29 72.5% 
Paalai 0 0% 
 
 
 
Inference  
According to Thinai the highest distribution 72.5% was noted in 
Neithal, in Marutham 12.5% and Kurinji 10%  and Mullai 5% were 
observed. 
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SITE OF LESION 
 
Site of Lesion No.of cases  
out of 40 Percentage % 
Scalp 1 2.5% 
Face 1 2.5% 
Lips 3 7.5% 
Abdomen 1 2.5% 
Upper Limb 1 2.5% 
Lower Limb 2 5.0% 
Multiple 31 77.5% 
 
 
Inference  
About 77.5% of cases were having multiple site of lesion. Lower limb 7.5% 
Scalp region 5%, lips 2.5%, Abdomen 2.5%, upper limb 2.5%, face 2.5%. 
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PARUVA KAALAM 
Paruvakaalam Months No.of cases 
out of 40 Percentage % 
Kaar Kaalam Avani- Purattasi  (Mid Aug-Mid Oct) 15 37.5% 
Koothir Kaalam  Ippasi,-Karthigai (Mid Oct – Mid Dec) 4 10% 
Munpani Kaalam Margazhi,-Thai  (Mid Dec – Mid Feb) 0 0% 
Pinpani Kaalam Maasi,-Panguni  (Mid Feb – Mid april) 2 5% 
Elavenil Kaalam Chithirai,-Vaigasi  (Mid April – Mid June) 8 20% 
Muthuvenil Kaalam Aavi- Aadi (Mid June – Mid Aug) 19 47.5% 
 
 
Inference  
According to paruvakaalam highest incidence 47.5% were noted in  
Muthuvenil kaalam 37.5% cases were noted in Kaarkaalam, 20% were 
noted in Elavenil kaalam 10% were noted in Koothir kaalam. Only 5% were 
noted in Pinpani kaalam. 
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DERANGEMENT IN THE TYPES OF VATHAM 
Vatham No.of Case Out of 40 Percentage % 
Praanan 2 5% 
Abaanan 5 12.5% 
Viyanan 10 25% 
Uthanan 0 0% 
Samanan 0 0% 
Nagan 0 0% 
Koorman 5 12.5% 
Kirugaran 0 0% 
Devathanan 0 0% 
Dhananjeyan 0 0% 
 
 
Inference  
According to classification of Vatham, Abanan and Koorman were 
deranged in 12.5% of cases, Piranan was deranged 5%,Viyanan was 
deranged in 25% of cases. 
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DERANGEMENT IN TYPES OF PITHAM 
 
Pitham No.of Cases Out of 40 Percentage % 
Anar pitham 0 0% 
Ranjagam 20 50% 
Saathagam 0 0% 
Prasagam 40 100% 
Alosagam 5 12.5% 
 
 
Inference 
According to Pitham Prasagam was deranged in 100% of cases, 
Ranjagam was deranged in 50%, Alosagam was deranged 12.5%.  
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DERANGEMENT TYPES OF KABAM 
 
Types of kabam No.of Case  
out of 40 Percentage % 
Avalambagam 2 5% 
Kilethagam 0 0% 
Pothagam 0 0% 
Tharpagam 5 12.5% 
Santhigam 10 25% 
 
 
Inference 
According to Kabam Santhigam was deranged in 25%, Tharpagam 
was deranged in 12.5%, Avalambagam was deranged in 5% of cases. 
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UDAL KATTUGAL 
Udal Kattugal No.of Cases Out of 40 Percentage % 
Saaram 40 100% 
Senneer 40 100% 
Oon 0 0% 
Kozhuppu 0 0% 
Enbu 10 25% 
Moolai 0 0% 
Sukkilam / 
Sironitham 0 0% 
 
 
Inference 
Saaram, Senneer were affected in 100% of cases Enbu was affected in 
25% . 
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ENN VAGAI THERVU 
 
Enn Vagai 
Thervu 
No.of Cases  
Out of 40 Percentage % 
Naa 5 12.5% 
Niram 40 100% 
Mozhi 0 0% 
Vizhi 5 12.5% 
Sparism 0 0% 
Malam 5 12.5% 
Moothiram 0 0% 
 
 
Inference 
Niram was affected in 100% of cases Naa, Vizhi, Malam were 
affected in 12.5% . 
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DISTRIBUTION OF NAADI AMONG THE PATIENT WITH 
SWETHAKUTTAM 
Naadi No. of Cases Out of 40 Percentage % 
Vali Azhal 14 35% 
Vali Iyyam 2 5% 
Azhal Vali 22 55% 
Azhal Ayyam 2 5% 
Iyyam Vali 0 0% 
Iyyam Azhal 0 0% 
 
 
 
Inference 
Vali Azhal was observed in 35%, Azhal Vali was observed in 55% 
Vali Ayyam was observed in 5%, Azhal Ayyam was observed in 5% 
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NEIKURI REFERENCE 
 
Neikuri  No.of Cases Out of 40 Percentage % 
Vali (spreads like snake) 15 37.5% 
Azhal (spreads like ring) 20 50% 
Iyyam (stands like pearl) 5 12.5% 
 
 
 
Inference  
50% shows Azhal neikuri,37.5% of cases show Vali neikuri and 
12.5% Iyyam neikuri. 
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CLINICAL FEATURES BEFORE & AFTER TREATMENT 
Signs & 
Symptoms 
No. of Cases 
Out of 40 
Percentage % 
Before 
Treatment 
No. of cases 
Improved from 
Signs & 
symptoms 
Percentage 
% 
After 
Treatment 
Colour of the skin 40 100% 31 77.5% 
Depigmentation of 
hair 3 10% 2 5% 
Itching 0 0% 0 0% 
Erythema 0 0% 0 0% 
Other Features     
Blurred vision 5 12.5% 5 12.5% 
Joint pain 10 25% 9 22.5% 
Constipation 5 12.5% 0 0% 
 
 
 
Inference 
Among 40 cases 31cases are improved from this disease which has 
been noted as appearance of enormous repigmented spots in affected areas. 
Among 3 cases 2 of them had improvement in colour change of hair 
from gray or white to normal colour or black among 10 cases 9 cases 
improved from joint pain constipation is relieved from noted cases. 
 
CLINICAL FEATURES BEFORE & AFTER TREATMENT 
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GRADATION OF RESULTS 
 
Results No.of Cases Out of 40 Percentage % 
Good 24 60% 
Moderate 9 22.5% 
Poor 7 17.5% 
 
 
 
 
Inference  
About 60% of cases had good Relief, 22.5% had moderate relief and 
17.5% poor relief. 
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.
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HAEMOGLOBIN LEVEL BEFORE AND AFTER TREATMENT 
 
Sl.No. OP No. Patients Name Age 
Haemoglobin Level 
gm% 
Before 
Treatment 
After 
Treatment 
1 8700 Mrs. Meenammal 45 7 11.6 
2 4646 Mrs. Gowri 24 10.8 12.6 
3 4890 Mrs. Lalitha 52 9.6 11.7 
4 4601 Mr. K.S.Kumar 20 9.0 12.2 
5 1438 Master. Rohith 12 9.2 11.5 
6 568 Ms. Lakshmi 19 8.0 11.6 
7 1528 Mr. Ellappan 50 8.0 10.5 
8 3091 Mr. Srinivasan 22 10.4 11.6 
9 067 Mrs. Thaiyalnayaki 55 9.0 10.5 
10 9057 Mrs. Madhuram 46 10.2 12.4 
11 7099 Mr. Krishnamoorthi 50 10.5 12.6 
12 490 Mr. Dhatchayani 50 10.6 13.2 
13 9746 Mr. Jayakumar 49 10.0 13.1 
14 344 Mr. Nainiyappan 50 9.6 12.4 
15 487 Mr. Gopal 48 9.8 11.0 
16 8387 Mr. Radhakrishnan 45 10.4 12.4 
17 1205 Mrs. Kala 42 10.8 12.6 
18 229 Master. Anil kumar 18 10.6 12.4 
19 1230 Mrs. Sathiyabavani 27 9.8 11.2 
20 4943 Mrs. Sowntharam 50 8.0 11.1 
 
 
 
 
80 
 
 
 
DISCUSSION 
 
Swetha Kuttam is an acquired idiopathic depigmentory condition and is 
characterized by completely depigmented macules and patches of varying sizes 
and shapes. 
 
The clinical study of Swetha Kuttam was carried out post graduate department of 
Maruthuvan Govt. Siddha Medical College, attached to Arignar Anna Hospital of 
Indian Medicine, Arumbakkam, Chennai – 106. 
 
40 patents of both sexes of various adult age groups satisfying the inclusion and 
exclusion criteria were selected.  All necessary investigation was done for them 
and photographs of the lesion were taken. A day before starting the trial treatment, 
clearning of mukkutram by purgation will be carried out by Agasthiyar 
Kuzhambu – 100 mg, early morning with hot water.  All the patients were treated 
with trial medicine.  Hence with the help of trial medicines results and observation 
are noted for this study. 
 
Let me make out these results on each category to arrive a better conclusion. 
5 (12.5%) Patients were in the age group between 40-55 yrs. 
12 (30%)  Patients were in the age group between 10-30 yrs. 
23 (57.5%) Patients were in the age group between 30-40 yrs. 
 
Gender Distribution: 
40 patients of both the gender were selected for the dissertation study. Among the 
26 (65%) were males, 14 (25%) were in females and the gender distribution was 
more or less equal. 
 
81 
 
Socio Economic Status 
About 52.5% of the patients were middle income group (Rs.10001 to 20001) and 
37.5% lower income (below Rs.10000) and 10% high income group above 
Rs.20000. 
 
Dietary Habits: 
28 (70%) Patients were taken mixed diet and only 12 (30%) taken vegetarian. 
 
Seasonal Variation: 
19 (47.5%) cases were admitted to trial in muthuvenil kaalam, 15 (37.5%) in 
Kaarkaalam, 4 (10%) Koothirkaalam, 2 (5%) Pinpani Kaalam, 8 (20%) Elavenil 
Kaalam. 
 
Etiology: 
About 33% unknown cases, 10% of the cases were of auto immune disease, and 
7.5% hereditary cases. 
 
Thinai: 
29 (72.5%) Patients belonged to Neithal Thinai 
5 (12.5%) Patients belonged to Marutham Thinai 
4 (10%) Patients belonged to Kurunchi Thinai 
2 (5%) Patients belonged to Mullai Thinai 
 
In Sidha literature the Marutham is mentioned as disease free land among the five 
lands. Because of various environmental changes in the life style Swetha Kuttam 
occurs irrespective of the land, maximum patients came from in and around 
Chennai which belongs to Neithal Thinai. 
 
82 
 
Reference of Mukkutram 
1. Vaatham 
 Viyanan was affected in 10 (25%), results in disability to move the joints  
 Pranan was affected in 2 (5%), results in dyspnoea. 
 Abaanan was affected in 5 (12.5%), results in constipation. 
 Koorman was affected in 5 (12.5%), results in visual impairment. 
 
2. Pitham 
Praasakam was affected in 40 (100%) patients, results in hypopigmentation 
of skin. 
Ranjagam was affected in 20 (50%) patients, results in decreased level of 
haemoglobin. 
 Alosagam was affected in 5 (12.5%) patients, results in visual impairment. 
 
Praasakam is responsible for the complexion of the skin. Due to defect in 
praasakam skin is changed in swethakuttam. 
 
3. Kabam 
Sandhigam was affected in 10 (25%) patients, results in disability to move 
the joints. 
 Avalambagam was affected in 2 (5%) patients, results in dyspnoea. 
 Tharpagam 5 (12.5%). 
 
Udal Kattugal 
• Saaram was affected in all the 40 (100%) cases, results in tiredness 
• Senneer was affected in 40 (100%) patients results in decreased level of 
haemoglobin. 
• Enbu was affected in 10 patients (25%) results in restricted movements in 
both knee joints. 
 
83 
 
Ennavagai Thervugal: 
• Niram was affected in all the (100%) cases because in Swetha Kuttam, the 
colour of skin changed into white. 
• Naa was affected in 5 (12.5%) cases results in paleness of the tongue. 
• Vizhi was affected 5 (12.5%) cases results in diminished vision. 
• Malam was affected in 5 (12.5%) cases results in constipation. 
• In Naadi, among 40 cases Vali Azal was noted in 35% of cases., Azalvali 
22 (55%) and Azal Ayyam 2 (5%) .  
• In Neikkuri, Pitha Neer was observed in 50% cases. 
 
Clinical Features before & after treatment  
Among 40 cases 33 cases are improved from this disease which has been noted as 
appearance of enormous repigmented spots in affected areas. 
Rest of the 7 cases had slight repigmented spots in affected areas. 
Among 3 cases of them had improvement in the colour change of hair from gray 
or white to normal colour or black. 
 
Trial Medicines: 
I Puvarasam Pattai Kudineer Chooranam 25 gm- 60ml (Internal) twice a day 
II Nuna Thylam – 30 ml (External) 
 
Patients were instructed to take the medicines regularly and apply the thylam 
twice a day and to expose the affected parts to sunlight.  Diet restrictions were 
strictly imposed and followed. 
 
Mode of action of Trial Medicine: 
Swetha Kuttam is mainly due to vitiation of Azhal Kuttram, increased Azhal 
Kuttram is brought to normal by Enippu Suvai, Kaippu Suvai. 
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The trial drug consist of  Thuvarpu Suvai and thus they decrease the azhal 
Kuttram by cool potency by nature. 
 
So I conclude the Puvarasam Pattai Kudineer Chooranam cures the Swatha 
Kuttam and it comes under the Ethirurai Maruthuvam. 
 
Chemical Analysis: 
The chemical analysis of Puvarasam Pattai Kudineer Chooranam shows the 
presence of  Iron, Zinc, Calcium, Potassium, Sugar, chloride. 
 
Pharamacological Report & Toxicological Evaluation: 
The drug also subjected to pharmacological and toxicological tests in rat models.  
The results revealed that the drug had very good haematinic effect. There were no 
signs of toxicity as could be judged by the absence of undersirable clinical 
manifestations. 
 
Bio Statistical Study: 
The bio-statistical report of the clinical trial shows significant result. 
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SUMMARY 
 
         Swetha kuttam has been chosen for the dissertation work by the author . 
          
Various literatures dealing with swetha kuttam have been collected from siddha 
and modern text books. 
 
40 patients of both sexes, various adult age groups satisfying the inclusion and 
exclusion criteria were selected.All necessary investigation was done for them and 
photographs of the lesions were taken. 
 
A day before starting the trial treatment, patients are given for neutralizing the 
mukkutram by purgation Agasthiyar kuzhambu 100mg early morning with hot 
water.All the patients were treated with trial medicines which are,  
 
1. Puvarasampattai kudineer choornam 
2. Nuna thylam 
 
The result obtained from the studies are summarized below Male 26 (65%), were 
affected more than female 14 (35%). The cases were noted in the age group 
ranging from 10-55 yrs. 
 
Middle classes 52.5% and lower 37.5% were more affected than upper classes 
10%. 
 
High incidence of swetha kuttam are found in neithal thinai 72.5% and 
muthuvenil kaalam 47.5%. 
 
On examination of uyir thathukkal the following were deranged in more number 
of cases. 
In vatham :  Viyanan 25%, and koorman were affected 12.5%. 
In pitham  :  Prasagam 100%, ranjagam 100%, alosagam12. 5% were  
affected. 
In kapham :  Avalambagam 5%, santhigam 37.5% was affected. 
86 
 
In udal kattugal:       Saaram 100%, seneer 100%, and enbu 25% were affected. 
 
In envagai thervu: Naa 12.5%, niram 100%, vizhi 12.5%, malam 12.5% were 
affected. 
       
Among the 40 patients responding to the trial medicines, 33 patients showed 
improvement which has been noted as appearance of chormous repigmented spots 
in affected areas.  The rest of 7 patients had slight repigmentation.  
 
Among 3 patients 2 of them had improvement in the colour change of the hair 
from gray or white to normal colour of the hair. 
 
The chemical studies of the trial drugs possess, Iron, Zinc, Sugar Calcium, 
Potassium, Chloride.  
 
The drug is also subjected to pharmacological and toxicological tests in rats as  
models. The results revealed that the drug had very effective results. There were 
no signs of toxicities that could be judged by the absence of undesirable clinical 
manifestations. 
 
 The bio-statistical report of the clinical trial shows significant result. 
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CONCLUSION 
 
- Swetha kuttam may occur due to various causes and it leads to mental 
stress and strain.hence,it is one of the cause of psychosomatic 
disorder.when the trial drug Puvarasampattai kudineer choornam (int),with 
Nuna thylum(ext) were administered to the swetha kuttam patients,it 
showed improvement in varying  degrees in all the cases. 
 
- In Swetha Kuttam Pitha Kutram is affected.  The affected kuttram is 
neutralized by thuvarppu suvai.  Thereby the trial medicine 
puvarasampattai kudinner choornam having the thuvarppu suvai acts on 
Ethirurai to cure the discease.  
 
- In Chemical Analysis the trial medicine contain Iron, it is very essential to 
induce erythropoiesis. 
 
- From the pharmacological study puvarasampattai kudineer choornam 
increase the haemoglobin level. 
 
- The puvarasampattai kudineer choornam does not produce any toxicity in 
preclinically.so it is non-toxic and safe drug for swetha kuttam. 
 
- No adverse effects were noticed during treatment period. The ingredient of 
puvarasampattai kudineer choornam of plant easily available and harmless 
to human being. 
 
From this clinical studies,I conclude that the trial  medicines which gives a 60% 
of improvement within minimum of 45 days to maximum of 90 days of 
treatment.further continuation of this medications for prolonged period of time 
may give complete cure in swetha kuttam. 
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ANNEXURE –I 
CHEMICAL ANALYSIS OF TRIAL MEDICINES 
Preparation of Sodium Carbonate extract: 2 gm of the sample is mixed  5 
gm of Sodium carbonate and taken in a 100 ml beaker and 20 ml of distilled water 
is added.  The solution is boiled for 10 minutes, cooled and then filtered.  The 
filtrate is called sodium carbonate extract. 
 
 
S.No. 
 
Experiment 
 
Observation 
Inference 
1 Test for Acid Radicals   
a. Test for Sulphate 
2 ml of the above prepared 
extract is taken in a test tube.  
To this add 2ml of 4% 
Ammonium oxalate solution. 
 
Absence of              
White  Precipitate 
 
Absent 
 
 
b. 2ml of extract is added with 
2ml of dilute hydrochloric acid 
until the effervescence ceases 
off.  Then 2ml barium chloride 
solution is added. 
 
Absence of              
White  Precipitate 
 
Absent 
2. Test for Chloride: 
2ml of extract is added with 
dilute nitric acid till the 
effervescence ceases.  Then 
2ml of silver nitrate solution is 
added. 
 
White precipitate is 
obtained  
 
Present  
 
 
 
 
 
3. Test for Phosphate 
2ml of the extract is treated 
with 2 ml of Ammonium 
molybdate  solution and 2ml of 
concentrated nitric acid. 
 
Absent of Yellow 
Precipitate. 
 
Absent 
 
 
 
4. Test for Carbonate: 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution. 
 
Absence of white 
precipitate 
 
Absent 
 
5. Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated 
Hydrochloric acid 
 
Absence of Rotten egg 
smelling 
 
Absent 
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6. Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid 
and viewed the test tube 
vertically down. 
 
Absence of reddish 
brown gas. 
 
Absent 
7. 
a. 
Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 
2ml of calcium chloride 
solution and heated.  
 
Absence of white 
precipitate 
 
Absent 
 
 
 
b. 5 drops of clear solution is 
added with 2ml of dilute 
sulphuric acid and slightly 
warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added.  
 
Absence of KMNO4 
solution discolourisation. 
 
Absent 
 
 
 
 
8. Test for Nitrite 
3 drops of the extract is placed 
on a filter paper.  On that, 2 
drops a Acetic Acid and 2 
drops of Benzidine solution is 
placed. 
 
Absence of yellowish red 
colour 
 
Absent 
9. Test for Borate 
2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
 
Absence of Green tinged 
flame 
 
Absent 
II. TEST FOR BASIC RADICALS   
10. Test for lead 
2 ml of the extract is added 
with 2 ml of Potassium iodide 
solution 
 
Absence of Yellow 
precipitate 
 
Absent 
11a Test for Copper 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric acid 
in a watch glass and introduced 
into the non luminous part of 
the flame. 
 
Absent of blue coloured 
flame. 
 
Absent 
b. 2ml of the extract is added with 
excess of Ammonia solution 
 
Absence of deep blue 
 
Absent 
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12. Test for Aluminium 
To the 2 ml of extract.  Sodium 
Hydroxide solution is added in 
drops to excess. 
 
Absence of     White 
precipitate. 
 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution is added. 
 
Absence of Blood red 
colour 
 
Absent 
b. To the 2 ml of extract, 2 ml of
Ammonium Thiocyanate
solution and 2 ml of
concentrated Nitric Acid is
added. 
 
Absent of Blood red 
colour. 
 
Absent 
14. Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
obtained 
 
Present 
15. Test for Calcium 
2 ml of the extract is added 
with 2 ml of 4% Ammonium 
Oxalate solution. 
 
White precipitate is 
obtained 
 
Present 
16. Test for Magnesium 
 2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
 
Absence of   White 
precipitate. 
 
Absent 
17. Test for Ammonium 
 2 ml of extract few ml of 
Nessler’s Reagent and excess 
of Sodium Hydroxide solution 
are added. 
 
 
Absent of Reddish 
brown precipitate  
 
Absent 
18. Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
 
Yellow precipitate is 
obtained 
 
Present 
19. Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame. 
 
Absence of Yellow 
colour flame 
 
Absent 
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20. Test for Mercury 
2 ml of the extract is treated 
with 2 ml of Sodium 
Hydroxide solution. 
 
Absence of yellow 
precipitate 
 
Absent 
21. Test for Arsenic 
2 ml of extract is treated with 2 
ml of silver Nitrate solution 
 
Absence of              
Yellow precipitate. 
 
Absent 
22. Test for Starch 
2ml of extract is treated with 
weak iodine solution 
 
Absent of Bluecolour. 
 
Absent  
23. Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added  10 drops of 
the extract and again boiled for 
2 minutes.  The colour changes 
are noted. 
 
Green colour is obtained. 
 
Present 
24. 
 Test of  the alkaliods   
2ml of the extract is treated 
with  2ml of potassium lodide 
solution 
 
Absent of Red colour  
 
Absent 
 
RESULTS:   
 
The given sample contains. 
(Puvarasampattai  Kudineer Choranam) 
Chloride, Zinc, Sugar, Iron.  
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TOXICITY STUDY ON POOVARASAM PATTAI 
KUDINEER CHOORANAM 
Animals  
 Mice of either sex weighing 25-30g and rats weighing 155-174g were 
obtained from the animal house of Vels University. The animals were used with 
the approval of the Institute animal ethics committee and obtained from Vels 
University, Chennai. They were fed with a balanced standard pellet diet and 
maintained under standard laboratory conditions, providing 24-280C temperature, 
standard light cycle (12 h light, 12 h dark) and water ad libitum. Animals were 
kept in cages with raised floors of wide mesh to prevent coprophagy. Animal 
welfare guidelines were observed during the maintenance period and 
experimentation. The rats were randomly assigned to control and different 
treatment groups, six animals per group. The animals were acclimatized for one 
week under laboratory conditions.  
ACUTE TOXICITY STUDY-OECD 425 GUIDELINES 
 Acute oral toxicity test for the Poovarasam Pattai Kudineer Chooranam 
was carried out as per OECD Guidelines 425. As with other sequential test 
designs, care was taken to ensure that animals are available in the appropriate size 
and age range for the entire study. The test substance is administered in a single 
dose by gavage using a stomach tube or a suitable intubation cannula. The fasted 
body weight of each animal is determined and the dose is calculated according to 
the body weight. After the substance has been administered, food was withheld 
for a further 2 hours in mice.  
 The animals were observed continuously for the first 4 h and then each 
hour for the next 24 h and at 6 hourly intervals for the following 48 h after 
administering of the test drug, to observe any death or changes in general 
behaviour and other physiological activities. Single animals are dosed in sequence 
usually at 48 h intervals. However, the time interval between dosing is determined 
by the onset, duration, and severity of toxic signs. Treatment of an animal at the 
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next dose was delayed until one is confident of survival of the previously dosed 
animal.  
Observation of toxicity signs: General behavior, respiratory pattern, 
cardiovascular signs, motor activities, reflexes, change in skin and fur, mortality 
and the body weight changes were monitored daily. The time of onset, intensity, 
and duration of these signs, if any, was recorded.  
SUB-ACUTE TOXICITY  
 The 28 days repeated dose oral toxicity study was carried out on twenty 
four rats and were divided into 4 groups of 6 in each. The rats received daily 
control (2% CMC 2ml/kg) and 100, 200, 400mg/kg/day Poovarasam Pattai 
Kudineer Chooranam by oral gavage, once daily for 28 consecutive days. The 
animals were then observed daily for gross behavioural changes and any other 
signs of subacute toxicity.  
 The body weight changes, food and water consumption was calculated. At 
the end of the 28 days they were fasted overnight, each animal was anaesthetized 
with diethylether, following which they were then dissected and blood samples 
were obtained by cardiac puncture into heparinised tubes. The blood sample 
collected from each rat was centrifuged with 3000 X g at 4oC for 10 min to 
separate the serum and used for the biochemical assays.  
Hematological and blood biochemical analyses:  
 At the end of the study, all animals were kept fasted for 16-18 h and then 
anesthetized with anesthetic ether on the 28th day. Blood samples for 
hematological and blood chemical analyses were taken from retro orbital vein. 
Heparinized blood samples were taken for determining complete blood count 
(white blood cell count, differential white blood cell count, platelet count, red 
blood cell count, hematocrit, and hemoglobin) by semiautomated hematology 
analyzer. The serum from non-heparinized blood was carefully collected for blood 
chemistry and enzyme analysis glucose, creatinine, total protein, albumin, total 
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and direct bilirubins, serum glutamate-oxaloacetate transaminase (SGOT), serum 
glutamate pyruvate transaminase (SGPT), and alkaline phosphatase (ALP)) were 
automatically determined using autoanalyzer. 
Necropsy:  
 All rats were sacrificed after the blood collection. The positions, shapes, 
sizes and colors of internal organs were evaluated. The Spleen, Testes, Pancrea, 
Lung, Liver, Brain, Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues 
were excised from all rats to visually detect gross lesions, and weighed to 
determine relative organs’ weights and preserved in 10% neutral formalin for 
histopathological assessment. The tissues were embedded in paraffin, and then 
sectioned, stained with haematoxylin and eosin and were examined 
microscopically. 
Statistical analysis 
 Values were represented as mean ± SEM. Data were analysed using one-
way analysis of variance (ANOVA) and group means were compared using the 
Tukey-Kramer Multiple Comparison test using GraphPad Instat-V3 software. P 
values < 0.05 were considered significant. 
RESULTS 
 All the animals from control and all the treated dose groups up to 400 
mg/kg survived throughout the dosing period of 28 days. No signs of major or 
significant intoxication were observed in animals from lower to higher dose 
groups during the dosing period of 28 days. Animals from all the treated dose 
groups exhibited comparable body weight gain with that of controls throughout 
the dosing period of 28 days. Food consumption of control and treated animals 
was found to be comparable throughout the dosing period of 28days. 
Ophthalmoscopic examination, conducted prior to and at the end of dosing period 
on animals from control and all the treated dose groups did not reveal any 
abnormality.  
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 The results of haematological investigations revealed no significant 
changes in the values of different parameters investigated when compared with 
those of respective controls except RBC and Hb (P<0.01) count. A slight increase 
in total RBC count values were obtained for animals in the dose group of 400 
mg/kg only. Results of Biochemical investigations revealed no significant changes 
in the values of different parameters studied when compared with those of 
respective controls; however, the values obtained were within normal biological 
and laboratory limits. Functional observation tests conducted at termination 
revealed no abnormalities.  
 Urine analysis, conducted at the end of the dosing period in week 4 
revealed no abnormality attributable to the treatment. Organ weight data of 
animals sacrificed at the end of the dosing period was found to be comparable 
with that of respective controls. Gross pathological examination did not reveal any 
abnormality. Histopathological examination did not reveal any abnormality. 
CONCLUSION 
No mortality, no treatment related clinical signs were observed throughout 
the study period. In respect of initial body weight, there was increase of 
body weight and there were no statistical changes in body weights in any 
groups as compared to control animals. So, these changes in rats had no 
biological significance. No other treatment-related changes in clinical 
chemistry parameters. Gross necropsy examination revealed no treatment-
related lesions. Hence, it can be concluded that the drug Poovarasam Pattai 
Kudineer Chooranam is well tolerable and practically non toxic in animal 
models upto 400mg/kg dose level and can be used clinically for various 
ameliorations. 
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Table 5. Body wt (g) of rats exposed to Poovaram Pattai Kudineer Chooranam for 28days. 
Dose (mg/kg/day) 
Days 
1 7 14 21 28 
Control 174.42±5.26 178.49±4.18 181.22±5.22 186.42±4.70 188.12±5.44 
100 158.34±4.20 163.55±5.24 165.18±5.80 168.54±5.00 176.52±4.10* 
200 167.10±4.17 169.00±4.40 172.04±5.33 174.10±4.15 176.62±5.65 
400 155.19±5.23 158.00±5.65 160.12±4.38 161.58±5.47 165.78±4.30 
Values are mean ± S.E.M. (Dunnet ’t' test). *P<0.05. Vs. Control group N=6. 
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Table 6. Food (g/day) intake of rats exposed to Poovaram Pattai Kudineer Chooranam for 28days. 
Dose (mg/kg/day) Days (gms/rats) 
1 7 14 21 28 
Control 47.02±2.52 45.21±2.48 45.12±2.65 48.14±2.54 45.11±3.00 
100 44.28±2.60 44.40±2.17 45.42±2.45 46.10±2.26 46.19±3.00 
200 46.30±2.38 44.56±2.10 44.64±2.64 45.45±2.14 45.01±2.88 
400 45.15±2.26 45.22±2.85 48.10±2.20 47.23±2.55 49.20±2.18 
Values are mean ± S.E.M. (Dunnet ’t' test). nsP>0.05. Vs. Control group N=6. 
Table 7. Water (ml/day) intake of rats exposed to Poovaram Pattai Kudineer Chooranam for 28days. 
 
Dose (mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 51.26±2.55 52.66±3.30 54.15±3.16 52.52±3.10 51.00±3.50 
100 50.14±2.14 50.10±3.85 55.20±4.49 48.12±3.18 48.55±2.95 
200 48.07±2.23 45.21±3.58 48.58±3.34 46.18±2.46 49.44±3.28 
400 50.00±3.45 52.76±3.50 50.30±3.15 47.25±3.12 50.58±3.52 
Values are mean ± S.E.M. (Dunnet ’t' test). nsP>0.05. Vs. Control group N=6. 
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Table 8. Hematological parameters after 28days treatment with Poovaram Pattai Kudineer Chooranam in rats. 
Parameter Control 100 mg/kg 200 mg/kg 400 mg/kg 
Red blood cell (mm3) 15.00±0.50 14.90±0.58 15.15±0.47 16.28±0.52 
HB (%) 14.18±0.36 15.21±0.30 16.57±0.42** 17.22±0.40** 
Leukocyte (x103/Cu.mm) 8.20±1.7 8.24±0.82 8.12±1.10 8.32±1.31 
Platelets(K/µl) 442±20.18 456±30.42 447±30.20 472±33.46 
MCV (gl) 52.40±4.81 52.28±4.38 53.08±3.32 52.18±4.00 
N 45.45±1.38 45.20±1.12 41.84±0.82 45.10±3.14 
L 55.12±2.42 54.84±3.41 53.28±3.52 55.12±3.48 
M 1.40±0.30 1.40±0.31 1.40±0.29 1.38±0.22 
E 1.00±0.00 1.00±0.12 1.00±0.11 1.00±0.10 
B 0±0.00 0±0.00 0±0.00 0±0.00 
ESR(mm) 1±00 1±00 1±00 1±00 
PCV 45.55±2.60 45.08±2.54 45.10±3.00 45.20±3.02 
Values are mean ± S.E.M. (Dunnet ’t' test). **P<0.01. Vs. Control group N=6. 
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Table 9. Effect of treatment with Poovaram Pattai Kudineer Chooranam biochemical parameters. 
 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total Bilirubin (mg/dL) 0.27±0.05 0.26±0.06 0.25±0.05 0.25±0.04 
Bilirubin direct (mg/dL) 0.21±0.07 0.21±0.09 0.20±0.05 0.21±0.06 
ALP (U/L) 102.22±7.12 105.14±8.00 105.10±7.24 104.48±9.20 
SGOT (U/L) 114.24±5.18 112.32±4.50 110.51±5.22 112.00±4.26 
SGPT(U/L) 35.14±2.00 34.72±2.04 35.82±2.21 34.23±2.18 
Total Protein(g/dl) 7.00±1.32 7.14±1.21 7.54±0.22 8.00±0.23 
Albumin(g/dl) 3.15±0.20 3.18±0.21 3.40±0.20 3.42±0.22 
Globulin(g/dl) 5.00±0.11 5.10±0.12 4.88±0.10 4.84±0.12 
Values are mean of 6 animals ± S.E.M. nsP>0.05. Vs. Control group N=6. 
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Table-10 RFT 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Urea(mg/dL) 5.36±1.85 4.80±2.10 5.0±2.00 5.11±1.45 
Creatinine (mg/dL) 0.71±0.06 0.70±0.05 0.71±0.06 0.71±0.05 
Uric acid (mg/dL) 3.51±0.17 4.00±0.12* 4.10±0.12* 4.00±0.11* 
Na m.mol 116.85±5.16 115.2±5.45 117.42±5.00 117.14±5.12 
K m.mol 5.22±2.81 5.52±1.10 5.10±1.11 6.12±2.02 
Cl m.mol 100.08±4.10 101.00±5.14 99.16±4.00 100.21±5.18 
Values are mean ± S.E.M. *P<0.05. Vs. Control group N=6. 
Table-11. Lipid Profile 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Total cholestrol(mg/dL) 78.15±2.52 74.18±2.44 75.12±3.00 76.00±2.10 
HDL(mg/dL) 125.00±2.54 121.42±2.70 124.14±3.52 125.42±2.28 
LDL(mg/dL) 42.55±2.32 42.58±3.12 41.15±2.80 42.00±3.00 
VLDL(mg/dl) 25.30±2.28 25.48±2.15 25.04±2.44 25.00±2.22 
Triglycerides (mg/dl) 28.42±3.00 27.51±2.40 26.88±3.12 27.15±2.74 
Blood glucose(mg/dl) 95.15±4.25 95.12±4.05 94.14±5.04 94.54±2.41 
Values are mean ± S.E.M. nsP>0.05. Vs. Control group N=6. 
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Table-12 Urine Analysis 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid Slightly cloudy Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >7.5 >7.5 
Protein Nil 1+ 1+ 2+ 
Glucose Nil Nil Nil Trace 
Bilirubin -ve -ve -ve -ve 
Ketones -ve -ve -ve -ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Normal Normal Normal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 13. Effect of oral administration of Poovaram Pattai Kudineer Chooranam on organ weight 
Dose (mg/kg) Control 100 mg/kg 200 mg/kg 400 mg/kg 
Liver (g) 3.12±0.10 3.10±0.15 3.15±0.12 3.15±0.15 
Heart (g) 0.34±0.04 0.33±0.05 0.35±0.04 0.34±0.04 
Lung (g) 0.45±0.16 0.44±0.16 0.43±0.15 0.44±0.15 
Spleen (g) 0.45±0.05 0.45±0.04 0.46±0.04 0.45±0.05 
Ovary (g) 1.20±0.16 1.22±0.15 1.22±0.15 1.24±0.14 
Testes (g) 2.38±0.11 2.41±0.20 2.40±0.22 2.40±0.20 
Brain (g) 2.00±0.12 2.04±0.10 2.06±0.12 2.32±0.14 
Kidney (g) 0.80±0.04 0.81±0.04 0.80±0.04 0.82±0.05 
Stomach (g) 1.21±0.12 1.24±0.10 1.22±0.12 1.21±0.10 
Values are mean of 6 animals ± S.E.M. (Dunnet ’t' test). nsP>0.05 Vs. Control group N=6. 
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HAEMATINIC ACTIVITY OF POOVARASAM PATTAI 
KUDINEER CHOORANAM IN PHENYLHYDRAZINE INDUCED 
ANEMIC RATS 
INTRODUCTION 
Anaemia is very common and the incidence is likely to increase in future, there is 
need to prevent it or seek for more cost-effective and better treatment strategies. 
Iron plays a significant role in the haematopoiesis. However, the therapeutic 
potential of the herbs cannot be established on the basis of available iron content 
alone as other factors play a role in the absorption of iron in the body. Excess 
doses of iron by ingestion are a pain in stomach due to lining of ulceration. This is 
accompanied by nausea and vomiting. The iron may passes deeper into the body 
and damages internal organs particularly the brain, liver and metabolic acidosis 
develops. The pragmatic use of different formulation of native iron in the 
treatment of anemia is time of immemorial. Man throughout the ages has 
depended on his immediate environment for food and medication. Most 
especially, man has consistently resorted to plants for solution to the myriad of 
health problems challenging him.  
 
The Thespesia populnea belongs to Malvaceae family is a fairly large, quick-
growing evergreen tree distributed mainly along the coastal regions throughout 
India. The parts of this plant are used externally in scabies, psoriasis and other 
skin diseases. The plant is astringent, acrid, depurative, haemostatic, antidiarrheal 
and antibacterial. (+)-Gossypol was reported to be present in the bark of the plant 
and it was found to be optically active.  
 
Traditional herbal practitioners have made several claims on numerous herbal 
preparations with specific claim on the efficacy of parts of Thespesia papulnea in 
the treatment of several disease conditions. According to the literature, the 
improvement in the heamoglobin level in these diseased conditions will enhance 
the beneficial treatment outcome. Hence in the present investigation, the 
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traditionally used siddha medicament Poovarasam Pattai Kudineer Chooranam 
was evaluated for its antianemic property in terms of haematinic action in 
scientific manner using phenylhydrazine induced anemic animal model. 
 
MATERIALS AND METHODS 
Drug material 
 
Poovarasam Pattai Kudineer Chooranam was collected from siddha commercial 
lab and 2gms of this chooranam was suspended in 10ml of 2% CMC solution to 
achieve 200mg/ml stock solution and used in this study. The resulting suspension 
was then filtered. The filtrate was stored in a refrigerator until use.  
Animals 
Male albino rats (150-180g) and Mice of either sex weighing 25-30g were used 
for the study. The rats were housed in wire-mesh cages with a 12 h light/dark 
cycle. They had continuous access to food and water during the entire period of 
experimentation. 
Acute toxicity study 
Single dose acute oral toxicity test for the Poovarasam Pattai Kudineer 
Chooranam was carried out as per OECD Guidelines 425. Animals were observed 
individually after dosing at least once during the first 30 minutes, periodically 
during the first 24 hours, with special attention given during the first 4 hours, and 
daily thereafter, for a total of 14 days, except where they need to be removed from 
the study and humanely killed for animal welfare reasons or are found dead.  
 
All observations are systematically recorded and Observations include changes in 
skin and fur, eyes and mucous membranes, and also respiratory, circulatory, 
autonomic and central nervous systems, and somatomotor activity and behaviour 
pattern. Attention was directed to observations of tremors, convulsions, salivation, 
diarrhoea, lethargy, sleep and coma. The principles and criteria summarised in the 
106 
 
Humane Endpoints Guidance Document taken into consideration. Animals found 
in a moribund condition and animals showing severe pain or enduring signs of 
severe distress was humanely killed.  
Evaluation of Haematinic Activity  
Six rats were kept as normal control group (Group 1), while 24 rats were made 
anaemic by oral intubations of phenylhydrazine (10 mg/kg body weight) daily for 
8 days. Rats that developed anaemia with haemoglobin concentration <14 g/dl 
were recruited for the study. Anaemic rats were randomly divided into 5 groups (2 
to 6) and treated as follows: Group 1: received distilled water (1 ml) daily (normal 
control), Group 2: received 2% CMC (1 ml) daily (anaemic control), Group 3: 
received oral single dose of the Poovarasam Pattai Kudineer Chooranam 
100mg/kg body weight/day Group 4: received oral single dose of the Poovarasam 
Pattai Kudineer Chooranam 200mg/kg, Group 5: received oral single dose of the 
Poovarasam Pattai Kudineer Chooranam 400mg/kg Group 6: received oral single 
dose of the heamatinic syrup 2ml/kg body weight/day. The treatment was 
continued for 2 weeks.  
Haematological investigation 
Blood was collected from the retro orbital vein of experimental animals after an 
overnight fast (T=0) and after 1 and 2 weeks of treatment with Poovarasam Pattai 
Kudineer Chooranam, was used for the determination of red blood cell count 
(RBC), haemoglobin (Hb) concentration and packed cell volume (PCV). The 
mean cell volume (MCV), mean cell haemoglobin (MCH) and the mean cell 
haemoglobin concentration (MCHC) were calculated. 
Statistical analysis 
Experimental data was analysed using analysis of variance (ANOVA) and 
Dunnet’s ‘t’ test to determine significant differences between means. The 
statistical analysis system (INSTAT-V3) package was used for this analysis. 
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RESULTS AND DISCUSSION 
Anaemia is one of the most widespread disorders of blood which affect the 
populations of all ages throughout the world. It is a public health problem that 
affects populations in both rich and poor countries. However, the incidence of this 
disorder is higher in the developing countries than in the developed countries due 
to poverty, malnutrition and lack of hygiene. The situation is aggravated by 
factors such as nutritional deficiencies and high prevalence of parasitic 
gastrointestinal infections which cause heavy loss of blood. It has been confirmed 
previously that intraperitoneal administration of phenylhydrazine decreased 
haemoglobin concentration, red blood cells number and haematocrit values.  
 
The phytochemical screening of Poovarasam Pattai Kudineer Chooranam revealed 
presence of alkaloids, flavonoids, saponins and terpenoids. The acute toxicity 
testing revealed no significant toxic signs or death up to doses of 2000 mg/kg. In 
the untreated control rats phenylhydrazine induced significant (p<0.05) decrease 
in Hb concentration, RBC, WBC level, indicating anaemia. The administration of 
the Poovarasam Pattai Kudineer Chooranam produced a significant (p<0.05) 
increase in the haematological parameters. The phenylhydrazine induced anaemia 
was significantly (p<0.05) reversed after 14 days treatment with the Poovarasam 
Pattai Kudineer Chooranam at the dose level of 400mg/kg towards almost normal. 
In the anemic control, the Hb was 12.21±1.34g/dl at day seven and this was 
improved to 13.00±0.42, 15.36±1.15 and 15.87±1.26g/dl at the dose levels 100, 
200 and 400mg/kg respectively.  Similarly, After 14 days of treatment with 
Poovarasam Pattai Kudineer Chooranam 400mg/kg, the Hb level was increased 
from 10.12 ± 1.00g/dl to 13.11 ± 1.05, 14.52 ± 1.92 and 16.33±1.53g/dl at the 
doses described earlier. Same kind of beneficial and significant (p<0.05) changes 
were recorded in the other haematological parameters and at the higher dose of 
the Poovarasam Pattai Kudineer Chooranam. The effect of commercially availed 
heamatinic syrup was comparable to those of the test drug. There was no change 
in other blood parameters like MCV, MCHC and MCH. On other hand, red blood 
cell count (p<0.01) in animals treated with 400mg/kg of Poovarasam Pattai 
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Kudineer Chooranam exhibit a statistically significant elevation when compared 
with control group. The main importance of this study is to correlate the positive 
or beneficial effects along with the cofactors like flavonoids and alkaloids in the 
treatment of various traditional claims of this drug. Factors like alkaloids, 
flavonoids, saponins, tannins, calcium, zinc, vitamins C and K are involving in the 
utilization of iron content by our body tissues. Especially vitamin C contributes to 
the bioavailability of iron in the body. Since, anemia causes important physiologic 
effects on the cardiovascular system, hormonal and metabolic effects can result in 
direct myocardial toxicity, myocardial hypertrophy, and salt and water retention, 
which could be harmful in patients with heart failure.  
 
Scientific studies failed to give any valid evidence of an association between 
circulating hemoglobin level and the severity of symptoms. Number of other 
conditions, such as malaria and haemoglobinopathies are also responsible because 
the RBC plays a primary role of transporting substances including nutrients, 
respiratory gases and other waste materials throughout the body. The WBC 
defends the body against pathogens and other foreign bodies. The platelets play 
the role of preventing blood loss. Therefore, severe alteration in the concentration 
of any of these haemopoietic components may be detrimental.  
 
At the nutritional level, the most current and primary cause of anaemia is the iron 
deficiency. A deficiency state can only be recognized, however, if there is 
unequivocal evidence of impairment to health. Values of biochemical or 
hematological variates that are lower than average, or lower than an arbitrarily 
chosen lower limit of normal, cannot be considered valid evidence of   
pathological deficiency, nor can an elevation of levels induced by increased 
intakes of a nutrient be accepted as evidence of an improvement in health. 
Approximately 30% of the world population are affected by an iron deficiency, 
making iron by far the most widespread nutrient deficiency worldwide.  
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About half of the iron deficient people suffer from the more severe form of iron 
deficiency anaemia. Anaemia has economic implications for the country because 
it can have profound effects on work performance and productivity. The people at 
the risk are the old persons, the young women in age to procreate and children. 
Iron deficiency anaemia can cause adverse pregnancy outcome, decrease immune 
function and has been recognized as an important cause of cognitive deficit in 
infants and young children. Despite the clinical belief that anemia causes 
symptoms, there seems to be little valid evidence of an increase in symptoms with 
low levels of circulating hemoglobin, or of a beneficial effect of iron therapy on 
wellbeing. 
 
CONCLUSION 
From the toxicity study, no treatment related toxic signs and symptoms was 
observed and the Poovarasam Pattai Kudineer Chooranam, at a dose of 400 mg/kg 
(p.o.), significantly increased the haemoglobin, and RBC count in anaemic rats 
indicating the haematinic effect. The presence of alkaloids, saponins, tannins was 
confirmed by the preliminary phytochemical study. These phytochemicals could 
be responsible for their anti-anaemic effects. 
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Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
No Dose 
mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 1000 + - - + - + - - - - - - - - - - - - - - 
2 2000 + - - + - + - - - - - - - - - - - - - - 
3 5000 + - - + - + - - - - - - - - - - - - +  - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 
14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
 
 
 
 
113 
 
 
 
Table 2: Effect of Phenylhydrazine (10mg/kg, p.o. daily for 7 days) alone on Hematological parameters. 
Parameters 
 
Group 1 
(Control) 
Group 2 
(anemic) 
Group 3 
(anemic) 
Group 4 
(anemic) 
Group 5 
(anemic) 
Group 6 
(anemic) 
Hb (g/dl) 18.00 ± 0.48 13.21±0.32** 13.56±0.24** 13.41±0.36** 14.12±0.31** 13.55 ± 0.29** 
PCV (%) 56.42 ±1.66 41.92 ± 2.74** 40.28 ± 2.26** 41.22 ± 2.44** 40.51 ± 2.15** 40.34 ± 2.48** 
RBC (x106/ml) 6.30 ± 0.21 4.28 ± 0.24** 4.28 ± 0.21** 4.54 ± 0.25** 4.47 ± 0.20** 4.20 ± 0.32** 
MCV (fl) 74.11 ± 2.72 82.45±4.02 86.18±5.35 85.55±4.24 86.11±5.65 81.99± 4.26 
MCH (pg) 22.65 ± 1.56 29.18±1.85 31.45±2.52* 30.15±2.28 30.12±1.88 30.00 ± 2.23 
MCHC (g/dl) 35.10 ± 0.52 33.34±0.72 33.27±0.80 34.11±0.98 34.15±1.06 30.75 ± 1.00* 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). *P<0.05; **P<0.01 Vs Control; *P<0.05; **P<0.01 Normal Vs Control.. 
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Table 3: Hematological parameter of rats after Seven days treatment with Poovarasam Pattai Kudineer. 
Parameters  Group 1 
(control) 
Group 2 
(anemic control) 
Group 3 
(5ml/kg) 
Group 4 
(10ml/kg) 
Group 5 
(20ml/kg) 
Group 6 
(Heamatinic 
syrup) 
Hb (g/dl) 18.56 ±1.33 12.21±1.34** 13.00±0.42* 15.36±1.15 15.87 ± 1.26 20.52 ±1.88 
PCV (%) 52.18 ±1.22  43.85±2.26 46.74±2.41 47.00±2.48 49.39±2.98 54.65 ±2.61  
RBC (x106/ml) 7.62±0.28 5.55±0.20** 6.29±0.14** 6.54±0.17** 7.28±0.15 8.55±0.19** 
MCV (fl) 77.24±2.22  78.10±2.47 80.32±2.83 80.12±2.14 80.00±3.00 76.52±2.68  
MCH (pg) 25.88±1.74  28.1±1.52 23.20±1.41 24.16±1.56 24.22±1.19 26.24±1.50  
MCHC (g/dl) 34.26±1.33  32.05±1.24  27.64±1.65* 26.00±1.21* 29.54±1.75 30.42±2.00 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). *P<0.05; **P<0.01 Vs Control; *P<0.05; **P<0.01 Normal Vs Control.. 
115 
 
 
 
Table 5: Hematological parameters of rats after 14 days treatment with Poovarasam Pattai Kudineer. 
Parameters  
 
Group 1 
(control) 
Group 2 
(anemic control) 
Group 3 
(5ml/kg) 
Group 4 
(10ml/kg) 
Group 5 
(20ml/kg) 
Group 6 
(Heamatinic 
syrup) 
Hb (g/dl) 18.48±1.85 10.12±1.00** 13.11±1.05 14.52±1.92 16.33±1.53 22.71±2.04 
PCV (%) 46.24±1.27 40.32±1.28* 42.35±1.62 41.22±1.38 42.38±1.12 55.22±1.32** 
RBC (x106/ml) 4.88±0.26 3.52±0.30* 3.40±0.22** 3.86±0.31 4.10±0.36 5.63±0.38 
MCV (fl) 73.43±2.52 90.02±2.45** 84.22±2.12** 81.35±1.62 78.56±2.19 74.05±2.37 
MCH (pg) 27.54±1.61 34.12±1.69 30.33±1.56 30.78±2.04 30.00±2.11 29.13±2.82 
MCHC (g/dl) 31.29±2.45 35.05±1.32 33.52±1.08 32.16±1.12 32.24±2.00 31.98±2.28 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). *P<0.05; **P<0.01 Vs Control; *P<0.05; **P<0.01 Normal Vs Control. 
116 
 
 
 
 
 
 
117 
 
 
 
 
 
 
118 
 
 
 
 
 
 
119 
 
 
BIOSTATISTICAL ANALYSIS 
Effect of Puvarasampattai Kudineer Chooranam on Hb level (gm%) in 
human subjects 
S.No Haemoglobin Level gm% 
Before Treatment After Treatment 
1 7 11.6 
2 10.8 12.6 
3 9.6 11.7 
4 9.0 12.2 
5 9.2 11.5 
6 8.0 11.6 
7 8.0 10.5 
8 10.4 11.6 
9 9.0 10.5 
10 10.2 12.4 
11 10.5 12.6 
12 10.6 13.2 
13 10.0 13.1 
14 9.6 12.4 
15 9.8 11.0 
16 10.4 12.4 
17 10.8 12.6 
18 10.6 12.4 
19 9.8 11.2 
20 8.0 11.1 
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Software: spss17 version 
Variables: Hb levels (gm %) – before treatment, after treatment  
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.624 
Before and after treatment mean difference: 2.34±0.86 (gm %) 
P Value (2 tailed): p<0.01 
 
Inference:  
The p value is significant (p<0.01).  So the treatment was significantly improving 
the Hb level (mg%). 
 
Treatment for Swetha kuttam 
The most popular statistical tool, namely, Fisher’s Exact Test analysis has been 
employed to analyses the effectiveness with the help of a hypothesis. 
 
Hypothesis 
There is no reducing symptoms among the patients for the treatment of Swetha 
kuttam.  
 
 
Symptoms 
Number of cases 
Reduced Not Reduced 
Depigmentation of Skin 28 
80% 
7 
20% 
Depigmentation of Skin 
and Hair 
3 
60% 
2 
40% 
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Software: spss17 version 
Number of cases: 40 
Test: Fisher’s Exact test 
Confidence Interval: 95% 
Result: 
P Value (2 tailed): p<0.05 
 
Inference:  
Since the p value is significant (<o.o5), The hypothesis is  not accepted. So there 
is significant reduced symptoms among the patients for the treatment of Swetha 
kuttam. Hence it is concluded that the treatment was effective and significant. 
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CONSENT FORM 
 
 
I certify that I have disclosed all the details about the study in the terms readily 
understood by the patients. 
 
DATE :        SIGNATURE 
 
 
         NAME 
 
 
 
CONSENT BY THE PATIENTS 
I has been informed to my satisfaction by the attending physician the purpose of 
the clinical trial and the nature of the drug treatment and follow up including the 
lab investigations to be performed to monitor and safeguard my body functions. 
 
I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give reasons for doing so. 
 
I exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of PUVARASAM KUDINEER CHOORNAM and 
NUNA THYLAM for the treatment of Swetha Kuttam. 
 
 
DATE :      SIGNATURE: 
 
 
       NAME: 
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§ ¿ ¡ Â ¡ Ç ¢Â ¢ý  ´ ô G¾ ø  À bÅ õ  
 
 
¾ ¢Õ .___________________________¬ ¸ ¢Â  ¿ ¡ ý  ______________Å Â J 
(____________________________________________________________
_____________________________________________________________
____________  Å º ¢ì Fõ  þ ¼ õ .)   ± ý  RÂ  ¿ ¢¨ d× ¼ ý  ± Ø ¾ ¢ì  ¦ ¸ ¡Lì Fõ  
´ ô G¾ ø  À bÅ õ . 
  
¿ ¡ ý  RNtj Fl;lk; ± ý Û õ  § ¿ ¡ Â ¡ ø  À ¡ ¾ ¢ì ¸ ô À ð L ¦ º ý ¨ d « ÃR º ¢ ¾  
Á Õ  JÅ  ¸ ø æ ¡ ¢Â ¢ø  (þ ¼ õ : « È¢ï % « ñ ½ ¡  þ ó ¾ ¢Â  Á Õ  JÅ Á ¨ d, 
« Õ õ À ¡ ì ¸ õ , ¦ º ý ¨ d -106.) ¿ ¼  ¾ ô À Lõ  º ¢ ¾  Á Õ  JÅ  ¬ Ã ¡ ö î º ¢ ã Ä õ  
º ¢¸ ¢î ¨ º  ¦ À È ± ý  RÂ ¿ ¢¨ d× ¼ ý  Ó Ø º õ Á ¾  ¨ ¾ . õ  ¦ ¾ ¡ ¢Å ¢ Jì  
¦ ¸ ¡ û ¸ ¢§ Èý . 
 
þ ó ¾  ¬ Ã ¡ ö î º ¢Â ¢ý  § ¿ ¡ ì ¸ õ , Á Õ  JÅ õ  ¦ º ö . õ Ó ¨ È, ¦ ¾ ¡ ¼ % 
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¦ ¸ ¡ û ¸ ¢§ Èý . 
 
þ ô À bì F 
 
 
 
 
 
¦ À Â %     : 
Ó ¸ Å ¡ ¢  : 
 
¿ ¡ û       : 
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 CASE SHEET PROFORMA FOR SWETHA KUTTAM 
GOVT. SIDDHA MEDICAL COLLEGE & HOSPITAL,  
CHENNAI – 106. 
POST GRADUATE DEPARTMENT BRANCH – I MARUTHUVAM 
 
 
IP/ OP NO :   NATIONALITY  : 
BED NO :   RELIGION   : 
WARD NO  :   OCCUPATION  : 
NAME :   INCOME   : 
SEX  :   DATE OF ADMISSION : 
PERMANENT ADDRESS :  DATE OF DISCHARGE : 
 
 
     DIAGNOSIS   : 
 
 
TEMPORARY ADDRESS :  MEDICAL OFFICER: 
 
Govt.Siddha Medical College & 
Hospital, Chennai – 600 106.  
 
 
COMPLAINT AND DURATION  : 
 
 
HISTORY OF PRESENT ILLNESS : 
 
 
HISTORY OF PAST ILLNESS  : 
 
 
PERSONAL HISTORY/HABIT  : 
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FAMILY HISTORY: 
 
GENERAL EXAMINATIONS 
 
Consciousness  : 
Built   : 
Anaemia  : 
Cyanosis  : 
Jaundice  : 
JVP   : 
Clubbing  : 
Lymphadenopathy : 
Pedal oedema  : 
Temparature  : 
Pulse Rate  : 
Respratory Rate : 
Blood Pressure : 
 
SIDDHA ASPECT 
I. YAAKKAI (udal) 
Vaatham : 
Pittham : 
Kabam : 
Kalappu : 
II. GUNAM: 
Satthuyam : 
Rajotham : 
Thamasam : 
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III. NILAM: 
Kurinchi : 
Mullai : 
Marucham : 
Neithal : 
Paalai  : 
IV. PARUVAKAALAM: 
Kaar (Avani – Purattasi) 
Koothir (Ippasi – Karthigai) 
Munpani (Margazhi – Thai) 
Pinpani (Maasi – Panguni) 
Elavenil (Chittirai – Vaikasi) 
Muthuvenil (Aani – Aadi) 
 
V. PORI – PULANGAL (SENSORY ORGANS) 
Mei – Sensation : 
Vaai – Taste  : 
Kan – Vision  : 
Mooku – Smell : 
Sevi – Hearing : 
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VI. KANMENTHRIYAM / KAMMAVIDAYAM (MOTOR ORGANS) 
Kai – Dhaanam : 
Kaal – Kamanam : 
Vaai – Vasanam : 
Eruvaai – Visarkkam : 
Karuvaai – Aanantham: 
VII. UYIR THAATHUKKAL 
A.       VAATHAM 
Praanam :   Naagan : 
Abaanan :   Koorman : 
Viyaanan :   Kirugaran : 
Uthaanan :   Devathatthan : 
Samaanan :   Thananjeyan : 
B. PITTHAM 
  Anala pitham  : 
  Ranjaga pitham : 
  Aalosaga pitham : 
  Saathaga pitham : 
  Praasaga pitham : 
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KABHAM 
Avalambagam : 
Kilethagam : 
Pothagam : 
Tharpagam : 
Santhigam : 
 
VIII. UDAL THAATHUKKAL 
Saaram: 
Senner : 
Oon  : 
Kozhuppu : 
Enbu  : 
Moolai  : 
Sukkilam / Suronitham : 
 
IX. ENVAGAI THERVUGAL 
 
Naadi  : 
Sparisam : 
Naa  : 
Niram  : 
Mozhi  : 
Vizhi  : 
 Malam: 
  Niram  : 
  Edai  : 
  Erugal  : 
  Elagal  : 
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Moothiram: 
 
i. Neerkuri : 
Niram  : 
Manam : 
Edai  : 
Nurai  : 
Enjal  : 
ii. Neikuri: 
 
CLINICAL PARAMETERS: 
 
       IST MONTH 
 
 
S. 
NO CLINICAL FEATURES 
DURING 1ST 
DAY OF 
TREATMENT 
PROGRESS 
 
  Ist Week IInd Week 
IIIrd 
Week 
IVth 
Week 
1 Hypopigmentation      
2 Area      
3 Shape      
4 Pruritus      
5 Erythema      
6 Depigmentation of hair      
7 Sensation      
8 Scaling      
 
+ = Present 
-  = Absent 
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IInd MONTH 
 
S. 
NO CLINICAL FEATURES 
PROGRESS 
Ist Week IInd Week IIIrd Week IVth Week 
1 Hypopigmentation     
2 Area     
3 Shape     
4 Pruritus     
5 Erythema     
6 Depigmentation of hair     
7 Sensation     
8 Scaling     
 
+ = Present 
-  = Absent 
 
IIIrd MONTH 
 
S. 
NO CLINICAL FEATURES 
PROGRESS 
Ist Week IInd Week IIIrd Week IVth Week 
1 Hypopigmentation     
2 Area     
3 Shape     
4 Pruritus     
5 Erythema     
6 Depigmentation of hair     
7 Sensation     
8 Scaling     
 
+ = Present 
-  = Absent 
 
EXAMNATION OF OTHER SYSTEMS 
 
1. Cardio vascular System : 
2. Respiratory System : 
3. Abdomen   : 
4. Central nervous system : 
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LABORATORY IN VESTIGATIONS 
1.   BLOOD 
      TC   : 
      DC   : P :  % L:  % E:  % M: % 
      ESR   : 
      ½ hour  : 
      1 hour  : 
      Hb (g/dl)  : 
      Blood sugar  : F :  PP: 
      Blood urea  : 
      Serrum cholesterol : 
2.  URINE 
     Albumin  : 
     Sugar   : 
     Deposits  : 
 
3.    MOTION 
Ova   : 
Cyst   : 
 
FINAL DIAGNOSIS : 
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TRIAL DRUG: 
MEDICINE: 
I Puvarasam Pattai Kudineer Choornam - 25 gm/60ml  twice day 
DURATION OF TREATMENT: 3 Months 
 
PATHIAM AND APATHIAM 
 
MEDICAL OFFICER SIGNATURE     
           
         H.O.D. 
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HISTOPATHOLOGY SLIDES
BONE
BRAIN
HEART
INTESTINE
KIDNEY
LIVER
LUNG
OVARY
PANCREAS
SPLEEN
STOMACH
TESTIS

